Exercise for rheumatoid arthritis of the hand by Williams, Mark A. et al.
Cochrane Database of Systematic Reviews
Exercise for rheumatoid arthritis of the hand (Review)
Williams MA, Srikesavan C, Heine PJ, Bruce J, Brosseau L, Hoxey-Thomas N, Lamb SE
Williams MA, Srikesavan C, Heine PJ, Bruce J, Brosseau L, Hoxey-Thomas N, Lamb SE.
Exercise for rheumatoid arthritis of the hand.
Cochrane Database of Systematic Reviews 2018, Issue 7. Art. No.: CD003832.
DOI: 10.1002/14651858.CD003832.pub3.
www.cochranelibrary.com
Exercise for rheumatoid arthritis of the hand (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
T A B L E O F C O N T E N T S
1HEADER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1ABSTRACT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2PLAIN LANGUAGE SUMMARY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4SUMMARY OF FINDINGS FOR THE MAIN COMPARISON . . . . . . . . . . . . . . . . . . .
12BACKGROUND . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
12OBJECTIVES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
12METHODS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
14RESULTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Figure 1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
Figure 2. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
Figure 3. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
Figure 4. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
Figure 5. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
Figure 6. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
26DISCUSSION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
28AUTHORS’ CONCLUSIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
29ACKNOWLEDGEMENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
29REFERENCES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
33CHARACTERISTICS OF STUDIES . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
47DATA AND ANALYSES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Analysis 1.1. Comparison 1 Exercise versus no exercise, Outcome 1 Hand function. . . . . . . . . . . . . 48
Analysis 1.2. Comparison 1 Exercise versus no exercise, Outcome 2 Pain. . . . . . . . . . . . . . . . 49
Analysis 1.3. Comparison 1 Exercise versus no exercise, Outcome 3 Hand impairment - power grip strength: short term. 50
Analysis 1.4. Comparison 1 Exercise versus no exercise, Outcome 4 Hand impairment - power grip strength: medium and
long term. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
Analysis 1.5. Comparison 1 Exercise versus no exercise, Outcome 5 Hand impairment - pinch grip strength. . . . 52
Analysis 1.6. Comparison 1 Exercise versus no exercise, Outcome 6 Participant adherence. . . . . . . . . . 53
Analysis 1.7. Comparison 1 Exercise versus no exercise, Outcome 7 General function. . . . . . . . . . . . 54
Analysis 1.8. Comparison 1 Exercise versus no exercise, Outcome 8 Disease activity. . . . . . . . . . . . . 55
55ADDITIONAL TABLES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
59APPENDICES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
60HISTORY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
60CONTRIBUTIONS OF AUTHORS . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
60DECLARATIONS OF INTEREST . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
61SOURCES OF SUPPORT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
62DIFFERENCES BETWEEN PROTOCOL AND REVIEW . . . . . . . . . . . . . . . . . . . . .
62INDEX TERMS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
iExercise for rheumatoid arthritis of the hand (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
[Intervention Review]
Exercise for rheumatoid arthritis of the hand
Mark A Williams1a , Cynthia Srikesavan2b , Peter J Heine2, Julie Bruce3, Lucie Brosseau4 , Nicolette Hoxey-Thomas2, Sarah E Lamb2
1Department of Sport andHealth Sciences, Oxford Brookes University, Oxford, UK. 2NuffieldDepartment of Orthopaedics, Rheuma-
tology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK. 3Warwick Clinical Trials Unit, University of
Warwick, Coventry, UK. 4School of Rehabilitation Sciences, Faculty of Health Sciences, University of Ottawa, Ottawa, Canada
aJoint first author. bJoint first author
Contact address: Sarah E Lamb, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS),
University of Oxford, Windmill road, Oxford, OX3 7LD, UK. sarah.lamb@ndorms.ox.ac.uk.
Editorial group: Cochrane Musculoskeletal Group.
Publication status and date: New, published in Issue 7, 2018.
Citation: Williams MA, Srikesavan C, Heine PJ, Bruce J, Brosseau L, Hoxey-Thomas N, Lamb SE. Exercise for rheumatoid arthritis
of the hand. Cochrane Database of Systematic Reviews 2018, Issue 7. Art. No.: CD003832. DOI: 10.1002/14651858.CD003832.pub3.
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
A B S T R A C T
Background
Rheumatoid arthritis is an inflammatory polyarthritis that frequently affects the hands and wrists. Hand exercises are prescribed to
improve mobility and strength, and thereby hand function.
Objectives
To determine the benefits and harms of hand exercise in adults with rheumatoid arthritis.
Search methods
We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (the Cochrane Library), MEDLINE, Embase, CINAHL,
AMED, Physiotherapy Evidence Database (PEDro), OTseeker, Web of Science, ClinicalTrials.gov and the World Health Organization
International Clinical Trials Registry Platform (WHO ICTRP) up to July 2017.
Selection criteria
We considered all randomised or quasi-randomised controlled trials that compared hand exercise with any non-exercise therapy.
Data collection and analysis
We used standard methodological procedures as outlined by the Cochrane Musculoskeletal Group.
Main results
We included seven studies involving 841 people (aged 20 to 94 years) in the review. Most studies used validated diagnostic criteria and
involved home programmes.
Very low-quality evidence (due to risk of bias and imprecision) from one study indicated uncertainty about whether exercise improves
hand function in the short term (< 3 months). On a 0 to 80 points hand function test (higher scores mean better function), the exercise
group (n = 11) scored 76.1 points and control group (n = 13) scored 75 points.
Moderate-quality evidence (due to risk of bias) from one study indicated that exercise compared to usual care probably slightly improves
hand function (mean difference (MD) 4.5, 95% confidence interval (CI) 1.58 to 7.42; n = 449) in the medium term (3 to 11 months)
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and in the long term (12 months or beyond) (MD 4.3, 95% CI 0.86 to 7.74; n = 438). The absolute change on a 0-to-100 hand
function scale (higher scores mean better function) and number needed to treat for an additional beneficial outcome (NNTB) were 5%
(95% CI 2% to 7%); 8 (95% CI 5 to 20) and 4% (95% CI 1% to 8%); 9 (95% CI 6 to 27), respectively. A 4% to 5% improvement
indicates a minimal clinical benefit.
Very low-quality evidence (due to risk of bias and imprecision) from two studies indicated uncertainty about whether exercise compared
to no treatment improved pain (MD -27.98, 95% CI -48.93 to -7.03; n = 124) in the short term. The absolute change on a 0-to-100-
millimetre scale (higher scores mean more pain) was -28% (95% CI -49% to -7%) and NNTB 2 (95% CI 2 to 11).
Moderate-quality evidence (due to risk of bias) from one study indicated that there is probably little or no difference between exercise
and usual care on pain in the medium (MD -2.8, 95% CI - 6.96 to 1.36; n = 445) and long term (MD -3.7, 95% CI -8.1 to 0.7; n =
437). On a 0-to-100 scale, the absolute changes were -3% (95% CI -7% to 2%) and -4% (95% CI -8% to 1%), respectively.
Very low-quality evidence (due to risk of bias and imprecision) from three studies (n = 141) indicated uncertainty about whether
exercise compared to no treatment improved grip strength in the short term. The standardised mean difference for the left hand was
0.44 (95% CI 0.11 to 0.78), re-expressed as 3.5 kg (95% CI 0.87 to 6.1); and for the right hand 0.46 (95% CI 0.13 to 0.8), re-
expressed as 4 kg (95% CI 1.13 to 7).
High-quality evidence from one study showed that exercise compared to usual care has little or no benefit on mean grip strength (in
kg) of both hands in the medium term (MD 1.4, 95% CI -0.27 to 3.07; n = 400), relative change 11% (95% CI -2% to 13%); and
in the long term (MD 1.2, 95% CI -0.62 to 3.02; n = 355), relative change 9% (95% CI -5% to 23%).
Very low-quality evidence (due to risk of bias and imprecision) from two studies (n = 120) indicated uncertainty about whether exercise
compared to no treatment improved pinch strength (in kg) in the short term. The MD and relative change for the left and right hands
were 0.51 (95% CI 0.13 to 0.9) and 44% (95% CI 11% to 78%); and 0.82 (95% CI 0.43 to 1.21) and 68% (95% CI 36% to 101%).
High-quality evidence from one study showed that exercise compared to usual care has little or no benefit on mean pinch strength of
both hands in the medium (MD 0.3, 95% CI -0.14 to 0.74; n = 396) and long term (MD 0.4, 95% CI -0.08 to 0.88; n = 351). The
relative changes were 8% (95% CI -4% to 19%) and 10% (95% CI -2% to 22%).
No study evaluated the American College of Rheumatology 50 criteria.
Moderate-quality evidence (due to risk of bias) from one study indicated that people who also received exercise with strategies for
adherence were probably more adherent than those who received routine care alone in the medium term (risk ratio 1.31, 95% CI 1.15
to 1.48; n = 438) and NNTB 6 (95% CI 4 to 10). In the long term, the risk ratio was 1.09 (95% CI 0.93 to 1.28; n = 422).
Moderate-quality evidence (due to risk of bias) from one study (n = 246) indicated no adverse events with exercising. The other six
studies did not report adverse events.
Authors’ conclusions
It is uncertain whether exercise improves hand function or pain in the short term. It probably slightly improves function but has little
or no difference on pain in the medium and long term. It is uncertain whether exercise improves grip and pinch strength in the short
term, and probably has little or no difference in the medium and long term. The ACR50 response is unknown. People who received
exercise with adherence strategies were probably more adherent in the medium term than who did not receive exercise, but with little
or no difference in the long term. Hand exercise probably does not lead to adverse events. Future research should consider hand and
wrist function as their primary outcome, describe exercise following the TIDieR guidelines, and evaluate behavioural strategies.
P L A I N L A N G U A G E S U M M A R Y
Exercise for rheumatoid arthritis of the hand
What is rheumatoid arthritis and what is exercise?
Rheumatoid arthritis is a joint disease that frequently affects the hands and wrists. Hand exercise includes mobility, strengthening (with
equipment, e.g. putty), or functional training.
Study characteristics
We found seven studies that compared hand exercise to non-exercise therapies in 841 adults with rheumatoid arthritis.
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Key results
On a 0-to-80-points hand function test, (higher scores mean better function), people who did hand exercises rated their function 1.1
points higher in the short term (less than 3 months). People who did not exercise rated their function at 75 points.
On a 0-to-100 scale (higher scores mean better function), compared with people who did not exercise, people who exercised rated their
hand function 5 points higher in the medium term (3 to 11 months) and 4 points higher in the long term (12 months or beyond).
People who did not exercise rated their function at 52.1 points.
On a 0-to-100-millimetre pain scale (lower scores mean less pain), people who exercised rated their pain 28mm lower in the short term.
People who did not exercise rated their pain at 68mm. On a 0-to-100-point scale (lower scores mean less pain), people who exercised
rated their pain 3 points lower in the medium and 4 points lower in the long term. People who did not exercise rated their pain at 51.4
points.
People who exercised had 3% and 4% improvement in the left and right-hand grip strength in the short term. People who did not
exercise measured 14.3 kg and 15.6 kg, respectively. People who exercised had 1% improvement in the average grip strength of both
hands in both medium and long term. People who did not exercise measured 13.2 kg.
People who exercised had 4% and 6% improvement in the left and right hand pinch strength in the short term. People who did not
exercise measured 1.2 kg and 1.2 kg, respectively. People who exercised had 2% and 3% improvement in the average pinch strength of
both hands in the medium and long term. People who did not exercise measured 4 kg.
It must be noted that although there were apparently better scores in hand function, pain, and grip and pinch strength with hand
exercise, these improvements may not equate to useful clinical benefits.
No studies evaluated the American College of Rheumatology 50 criteria (a measure that indicates greater than or equal to 50%
improvement in patient’s symptoms with treatment received).
Compared to participants who received usual care, those who also received hand exercises with strategies to stick with the programme
were 19% and 5% more likely to adhere to their programme in less than a year and beyond one year.
One study reported no adverse effects due to exercising. The remaining studies did not measure this outcome.
Quality of the evidence
The quality of the evidence was very low to high across outcomes. We lowered the quality of the evidence due to problems with lack
of blinding of participants to their allocated treatment and measurements, methods of allocation, and small study sizes.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Exercise compared to no exercise for rheumatoid arthritis of the hand
Patient or population: rheumatoid arthrit is of the hand
Setting: outpat ient therapy departments or home sett ings in Brazil, South Af rica, Sweden, the UK, and the USA
Intervention: exercise
Comparison: no exercise
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk with no exercise Risk with exercise
Hand funct ion - short
term (less than 3
months)
Grip funct ion test scale
of 0 to 80 points (higher
score indicates better
grip funct ion)
1 study that did not provide suf f icient data re-
ported no stat ist ically signif icant dif f erence be-
tween groups for grip funct ion scores. The ex-
ercise group (n = 11) measured 76.1, and the
control group (n = 13) measured 75 points on
Sollerman grip funct ion test scale of 0 to 80
points (higher scores mean better funct ion)
-------------- 24
(1 RCT)
⊕©©©
Very low 1
24 part icipants (1 RCT
included in narrat ive
synthesis)
Hand funct ion -medium
term (3 to 11 months)
Overall hand funct ion
subscale of the Michi-
gan Hand Quest ion-
naire, 0 to 100 (higher
scores mean better
hand funct ion)
Control group baseline
mean hand funct ion
was 52.1 points.
4.5 points higher
(1.58 to 7.42 higher)
-------------- 449
(1 RCT)
⊕⊕⊕©
Moderate 2
Absolute percentage
change (95% CI) = 5%
(2% to 7%)
Relat ive percentage
change (95% CI) = 9%
(3% to 14%)
NNTB (95%CI) = 8 (5 to
20)
An addit ional study that could not be included
in the meta-analysis provided change scores
on AIMS2. It f ound no stat ist ically signif icant
improvements in the change in hand and f inger
funct ion f rom baseline to 6 months for exercise
in comparison to joint protect ion advice
-------------- 36
(1 RCT)
36 part icipants (1 RCT
included in narrat ive
synthesis)
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Hand funct ion - long
term (12 months and
beyond)
Overall hand funct ion
subscale of the Michi-
gan Hand Quest ion-
naire, 0 to 100 (higher
scores mean better
hand funct ion)
Control group baseline
mean hand funct ion
was 52.1 points.
4.3 points higher
(0.86 to 7.74 higher)
-------------- 438
(1 RCT)
⊕⊕⊕©
Moderate2
Absolute percentage
change (95% CI) = 4%
(1% to 8%)
Relat ive percentage
change (95% CI) = 8%
(2% to 15%)
NNTB (95%CI) = 9 (6 to
27)
Pain - short term (less
than 3 months)
visual analogue scale
(0 to 100 mm, higher
score means more
pain)
Control group baseline
mean pain was 67.
6mm.a
27.98 mm lower
(48.93 to 7.03 lower)
--------------- 124
(2 RCTs)
⊕©©©
Very low 3
Absolute percentage
change (95%CI) = -28%
(-49% to -7%)
Relat ive percentage
change (95%CI) = -41%
(-72% to -10%)
NNTB (95%CI) = 2 (2 to
11)
Pain - medium term (3
to 11 months)
Pain subscale of M ichi-
gan Hand Outcomes
Quest ionnaire (0 to 100
points, higher score
means more pain)
Control group baseline
mean pain was 51.4
points.
2.8 points lower
(6.96 lower to 1.36
higher)
-------------- 445
(1 RCT)
⊕⊕⊕©
Moderate4
Absolute percentage
change (95% CI) = -3%
(-7% to 2%)
Relat ive percentage
change (95% CI) = -5%
(-14% to 3%)
NNTB was not applica-
ble as results were not
stat ist ically signif icant
Pain - long term (12
months and beyond)
Pain subscale of M ichi-
gan Hand Outcomes
Quest ionnaire (0 to 100
points, higher score
means more pain)
Control group baseline
mean pain was 51.4
points..
3.7 points lower
(8.1 lower to 0.7 higher)
-------------- 437
(1 RCT)
⊕⊕⊕©
Moderate4
Absolute percentage
change (95% CI) = -4%
(-8% to 1%)
Relat ive percentage
change (95% CI) = -7%
(-15% to 1%)
NNTB was not applica-
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ble as results were not
stat ist ically signif icant
Hand impairment -
power grip strength
(kg) - lef t hand -
short term (less than 3
months)
Control group base-
line mean power grip
strength, lef t hand was
14.3 kg.b
-------------- 141
(3 RCTs)
⊕©©©
Very low5
SMD 0.44 (95% CI 0.11
to 0.78)
SMD re-expressed in
kg: 3.5 kg (95% CI 0.87
to 6.1)
Relat ive percentage
change (95% CI) = 24%
(6% to 42%)
Absolute change and
NNTB were not applica-
ble as there is no maxi-
mum scale for measur-
ing grip strength
Hand impairment -
power grip strength
(kg) - right hand -
short term (less than 3
months)
Control group base-
line mean power grip
strength, right hand
was 15.6 kg.c
-------------- 141
(3 RCTs)
⊕©©©
Very low 5
SMD 0.46 (95% CI 0.13
to 0.8)
SMD re-expressed in
kg: 4 kg (95%CI 1.13 to
7)
Relat ive percentage
change (95% CI) = 26%
(7% to 45%)
Absolute change and
NNTB were not applica-
ble as there is no maxi-
mum scale for measur-
ing grip strength
An addit ional study that could not be included
in the meta-analysis measured grip strength at
4 weeks. It f ound no signif icant dif f erence in
maximal and average grip strength of dominant
and non-dominant hands between exercise (n =
11) and no-treatment (n = 13) groups
-------------- 24
(1 RCT)
-------------- 24 part icipants (1 RCT
included in narrat ive
synthesis)
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Hand impairment -
power grip strength
of both hands (kg) -
medium term (3 to 11
months)
Control group base-
line average power grip
strength of both hands
was 13.2 kg
1.4 kg higher
(0.27 lower to 3.07
higher)
-------------- 400
(1 RCT)
⊕⊕⊕⊕
High6
Relat ive percentage
change (95% CI) = 11%
(-2% to 13%)
Absolute change was
not applicable as there
is no maximum scale
for measuring grip
strength
NNTB was not applica-
ble as results were not
stat ist ically signif icant
An addit ional study that could not be included in
the meta-analysis measured gross grip strength
of the dominant hand f rom 0 to 6 months and
found no signif icant dif f erences between exer-
cise (n = 18) and control (n = 18) groups
-------------- (1 RCT) -------------- 36 part icipants (1 RCT
included in narrat ive
synthesis)
Hand impairment -
power grip strength of
both hands (kg) - long
term (12 months and
beyond)
Control group base-
line average power grip
strength of both hands
was 13.2 kg
1.2 kg higher
(0.62 lower to 3.02
higher)
-------------- 355
(1 RCT)
⊕⊕⊕⊕
High6
Relat ive percentage
change (95%CI) = 9% (-
5% to 23%)
Absolute change was
not applicable as there
is no maximum scale
for measuring grip
strength
NNTB was not applica-
ble as results were not
stat ist ically signif icant
An addit ional, 4-year study that could not be
included in the meta-analysis found stat ist ically
signif icant improvement in grip strength in the
exercise group compared to the no-exercise con-
trol group. At 48 months, the mean grip strength
in the exercise group (n = 19) was 105.7 mmHg
and in the control group (n = 25) was 44.1 mmHg
-------------- (1 RCT) -------------- 44 part icipants (1 RCT
included in narrat ive
synthesis)
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Hand impairment -
pinch grip strength (kg)
- lef t hand - short term
(less than 3 months)
Control group base-
line mean pinch grip
strength, lef t hand was
1.2 kg.d
0.51 kg higher
(0.13 higher to 0.9
higher)
-------------- 120
(2 RCTs)
⊕©©©
Very low 7
Relat ive percentage
change (95% CI) = 44%
(11% to 78%)
Absolute change and
NNTB were not applica-
ble as there is no maxi-
mum scale for measur-
ing pinch strength
Hand impairment -
pinch grip strength (kg)
- right hand - short term
(less than 3 months)
Control group base-
line mean pinch grip
strength, right hand
was 1.2 kg.e
0.82 kg higher
(0.43 higher to 1.21
higher)
-------------- 120
(2 RCTs)
⊕©©©
Very low 7
Relat ive percentage
change (95% CI) = 68%
(36% to 101%)
Absolute change and
NNTB were not applica-
ble as there is no maxi-
mum scale for measur-
ing pinch strength
Hand impairment -
pinch grip strength of
both hands (kg) -
medium term (3 to 11
months)
Control group base-
line average pinch grip
strength of both hands
was 4 kg
0.3 kg higher
(0.14 lower to 0.74
higher)
--------------- 396
(1 RCT)
⊕⊕⊕⊕
High8
Relat ive percentage
change (95%CI) = 8% (-
4% to 19%)
Absolute change was
not applicable as there
is no maximum scale
for measuring pinch
strength
NNTB was not applica-
ble as results were not
stat ist ically signif icant
1 study measured key grip strength of the domi-
nant hand f rom 0 to 6 months and found signif -
icant dif f erences between the exercise (n = 18)
and control (n = 18) groups
-------------- (1 RCT) -------------- 36 part icipants (1 RCT
included in narrat ive
synthesis)
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Hand impairment -
pinch grip strength of
both hands (kg) - long
term (12 months and
beyond)
Control group base-
line average pinch grip
strength of both hands
was 4 kg
0.4 kg higher
(0.08 lower to 0.88
higher)
-------------- 351
(1 RCT)
⊕⊕⊕⊕
High8
Relat ive percentage
change (95% CI) = 10%
(-2% to 22%)
Absolute change was
not applicable as there
is no maximum scale
for measuring pinch
strength
NNTB was not applica-
ble as results were not
stat ist ically signif icant
An addit ional, 4-year study that could not be
meta-analysed reported a stat ist ically signif icant
improvement in pinch strength in the exercise
group compared to the no-exercise control group.
At 48 months, the mean pinch strength in the
exercise group (n = 19) at 48 months was 54.8
mmHg and in the control group (n = 25) was 24.
8 mmHg
-------------- (1 RCT) -------------- 44 part icipants (1 RCT
included in narrat ive
synthesis)
ACR50 response -------------- -------------- (0 RCTs) -------------- No studies evaluated
this outcome.
Part icipant adherence -
medium term (3 to 11
months)
617 per 1000 808 per 1000
(710 to 913)
RR 1.31
(1.15 to 1.48)
438
(1 RCT)
⊕⊕⊕©
Moderate9
Absolute percentage
change (95% CI) = 19%
(9% to 29%)
NNTB (95%CI) = 6 (4 to
10)
Part icipant adherence -
long term (12 months
and beyond)
569 per 1000 621 per 1000
(530 to 729)
RR 1.09
(0.93 to 1.28)
422
(1 RCT)
⊕⊕⊕©
Moderate9
Absolute percentage
change (95%CI) = 5% (-
4% to 15%)
NNTB was not applica-
ble as results were not
stat ist ically signif icant
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Adverse events due to
exercise
No adverse events were
reported in 246 exer-
cise group part icipants
-------------- -------------- 490
(1 RCT)
⊕⊕⊕©
Moderate10
No adverse events were
reported in either the
exercise or control
group, therefore it was
not possible to calcu-
late an est imate of ab-
solute/ relat ive ef fect.
The other 6 studies
did not report adverse
events
*The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95%CI).
ACR50: American College of Rheumatology 50; AIMS2: Arthrit is Impact Measurement Scales 2; CI: conf idence interval; NNTB: number needed to treat for an addit ional
benef icial outcome; RCT : randomised controlled trial; RR: risk rat io; SMD: standardised mean dif ference
GRADE Working Group grades of evidence
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect.
Moderate quality: We are moderately conf ident in the ef fect est imate: the true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent.
Low quality: Our conf idence in the ef fect est imate is lim ited: the true ef fect may be substant ially dif f erent f rom the est imate of the ef fect.
Very low quality: We have very lit t le conf idence in the ef fect est imate: the true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
1Downgraded three levels for risk of bias (unclear risk of select ion bias, high risk of performance bias, unclear risk of detect ion
bias in measuring object ive hand funct ion, unclear risk of attrit ion bias) and imprecision (total number of part icipants less
than 400).
2Downgraded one level for risk of bias (high risk of performance and detect ion bias in measuring self reported hand funct ion).
3Downgraded three levels for risk of bias (unclear risk of select ion bias, high risk of performance and detect ion bias in
measuring self reported pain, unclear risk of attrit ion bias) and imprecision (total number of part icipants less than 400).
4Downgraded one level for risk of bias (high risk of performance and detect ion biases in measuring self reported pain).
5Downgraded three levels for risk of bias (unclear risk of select ion bias, high risk of performance bias, unclear or high risk of
detect ion bias in measuring object ive grip strength, unclear or high risk of attrit ion bias) and imprecision (total number of
part icipants less than 400).
6We considered the risk of performance bias with object ively measured grip strength not a signif icant reason for downgrading
the evidence.
7Downgraded three levels for risk of bias (unclear risk of select ion bias, high risk of performance bias, and unclear or high
risk of detect ion bias) and imprecision (total number of part icipants less than 400).
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8We considered the risk of performance bias with object ively measured pinch strength not a signif icant reason for downgrading
the evidence.
9Downgraded one level for risk of bias (high risk of performance and detect ion bias in measuring self reported part icipant
adherence).
10Downgraded one level for risk of bias (high risk of performance and detect ion bias in measuring self reported adverse
events).
a,b,c,d,eBuljina 2001 is the source document for the control group baseline data.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
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B A C K G R O U N D
Description of the condition
Rheumatoid arthritis (RA) is the most common inflamma-
tory polyarthritis, affecting approximately 1% of the population
(Symmons 2002). The aetiology is still unclear, but the patho-
genesis involves a series of immunological events that result in
chronic inflammation. Amajority of people with RA have involve-
ment of the hands and wrists (Horsten 2010). Frequent prob-
lems for the hands and wrists are inflammation, deformity, pain,
weakness, and restricted mobility, resulting in loss of function
(Adams 2004). There are common types of deformities at the
wrists,metacarpal-phalangeal, finger, and thumb joints. It has been
reported that hand strength in people with RA is 75% lower than
in the non-RA population (Jones 1991). Reduction in mobility of
the hands and wrists has also been documented (Horsten 2010).
Rheumatoid arthritis has no known cure, although there are in-
creasingly effective drug treatments for providing symptomatic
control (Katchamart 2010; Singh 2009; Suarez-Almazor 1998).
The goals of management are therefore to prevent or control joint
damage, improve hand function, and reduce pain.
Description of the intervention
The goals of management are to prevent or control joint damage,
improve hand function, and reduce pain. People with RA are often
referred to physical and occupational therapists to achieve these
goals. The three most common components of the therapies they
provide for handswithRA are exercise, joint protection advice, and
provision of functional splinting and assistive devices (Hammond
2004b; Steultjens 2004; Tuntland 2009).
How the intervention might work
Exercises are aimed at improving both themobility and strength of
the hand, and therefore improving functional ability. Exercisesmay
include simple through-range mobilising exercises to increase and/
or maintain range of motion in joints and surrounding soft tissues,
or strengthening exercises that use resistance from putty, a gel ball,
or elastic band to strengthen hand and wrist muscles. Exercises
usually incorporate the wrist due to the essential involvement of
the wrist in functional activities of the hand (i.e. positioning for
mechanical efficiency).
Why it is important to do this review
There is one previously published systematic review evaluating
studies of exercises for RA of the hand, which concluded that the
value of hand exercise for RA was uncertain (Wessel 2004). It did
not attempt a meta-analysis. A number of new trials have been
published since that review (e.g. Cima 2013; Lamb 2015; O’Brien
2006). To date, it is unclear if hand exercise for RA is effective.
O B J E C T I V E S
To determine the benefits and harms of hand exercise in adults
with rheumatoid arthritis.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included all randomised controlled trials or controlled clinical
trials that used quasi-randomised methods for treatment alloca-
tion.
Types of participants
We included trials in which adults (males and females aged above
18 years) with a diagnosis of RA participated. We excluded studies
that included a mixture of both adults and participants less than
18 years unless there were sufficiently detailed data to isolate the
findings for the adult participants.
Types of interventions
We included trials where exercise for RA of the hand was com-
pared with no treatment, usual care, placebo, medication, surgery,
therapeutic modalities, or other non-exercise therapies. We con-
sidered all forms of exercise such as range of motion, stretching,
and strength exercises and functional skills training.
Types of outcome measures
We included trials where the assessment had at least one measure
covering the following constructs. For outcomes assessing benefits
and harms, we extracted and defined outcomes at three time point
categories: short term (less than 3 months), medium term (3 to 11
months), and long term (12 months or beyond), and at the end
of the trial for adverse events. For trials that reported outcomes
at multiple time points, we selected the longest follow-up (Deeks
2011).
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Major outcomes
1. Hand function: consists of several combined components
including strength, mobility, co-ordination, and structure, and is
assessed objectively or by self report (e.g. measured by a subscale
of the Arthritis Impact Measurement Scale 2; Michigan Hand
Outcomes Questionnaire; Disabilities of Arm, Shoulder and
Hand questionnaire; Sequential Occupational Dexterity
Assessment; Arthritis Hand Function Test).
2. Pain (e.g. measured with a visual analogue scale).
3. Hand impairment measures: power grip strength (gross
hand grip).
4. Hand impairment measures: pinch grip strength (tip-to-tip/
tripod pinch grip).
5. American College of Rheumatology (ACR) 50 response
criteria (Felson 1995).
6. Participant adherence.
7. Adverse events due to exercise (exercise-induced injuries,
substantial increase in pain, increase in number of swollen or
tender joints, radiological damage to joints in the hand).
Minor outcomes
1. Hand impairment measures of range of motion, dexterity,
deformity, and hand stiffness.
2. General function (preferably measured by the Health
Assessment Questionnaire).
3. Disease Activity Score (DAS 28) (Van der Heijde 1993).
4. Patient satisfaction.
5. Costs.
6. Change in splint or assistive device usage.
Search methods for identification of studies
Electronic searches
We searched the Cochrane Central Register of Controlled Tri-
als (CENTRAL; published in the Cochrane Library, June 2017),
MEDLINE ( 1946 to 17 July 2017), Embase ( 1947 to 14
July 2017), CINAHL ( Cumulative Index of Nursing and Al-
lied Health Literature) ( 1982 to 25 July 2017), AMED ( Al-
lied and Complementary Medicine Database) ( 1985 to 25 July
2017), PEDro ( Physiotherapy Evidence Database), OTseeker,
Web of Science database, and the trial registers ClinicalTrials.gov
( clinicaltrials.gov) and World Health Organization International
Clinical Trials Registry Platform (WHO ICTRP) ( www.who.int/
ictrp/en) on 25 July 2017.
We consulted the Cochrane Musculoskeletal Group Information
Specialist to develop an optimal search strategy. There were search
strings for condition, intervention, body area, and identifying ran-
domised trials (according to the sensitivity-maximising version of
the Cochrane Highly Sensitive Search Strategy (Lefebvre 2011).
See Appendix 1 for the full search strategy. We modified the
MEDLINE search strategy for use in Embase, CINAHL, and the
Cochrane Library. In addition, investigation of the bibliographies
of retrieved studies and personal communication with recognised
leaders in the field completed the search for relevant studies. We
applied no language restrictions in the searches.
Data collection and analysis
Selection of studies
Two review authors (MW, PH) independently screened the titles
or abstracts obtained by our search of the databases and screened
the retrieved studies for inclusion. Each potential title was exam-
ined and, where titles were ambiguous, the abstract was sought.
Studies that clearly or potentially contained an exercise compo-
nent aimed at RA of the hand were retrieved for further evalua-
tion. We attempted to contact authors for additional information
where necessary.
Data extraction and management
Two of four review authors (MW, PH, NH-T, and JB) extracted
the data for each of the included studies. We developed a stan-
dard data extraction form to list study details. We systematically
extracted the following information: sample size, sample demo-
graphics (age, sex, disease duration), recruitment method, selec-
tion criteria, description of intervention and control groups (loca-
tion, type of exercise, frequency, duration, and intensity), super-
vision and delivery of intervention (trained professional, therapy
assistant, other, self administered, and group versus individual),
other methods, outcomes. We anticipated that the analysis would
mainly be concernedwith continuous outcomemeasures, inwhich
case mean changes from baseline with standard deviations were
extracted where possible.
Assessment of risk of bias in included studies
Two of four review authors (MW, PH, NH-T, and JB) assessed
the risk of bias.The six key domains to assess risk of bias were: ad-
equate sequence generation; allocation concealment and blinding
of participants, personnel, and outcome assessors; incomplete out-
come data; free of selective reporting; free of other biases (Higgins
2011a). Any disagreements were resolved by discussion or by con-
sulting a third review author (JB) when necessary.
Three of the authors of this systematic review, Sarah E Lamb,
Peter Heine, and Mark Williams, are authors of one of the studies
included in the review (Lamb 2015, also reported in Williams
2015). Sarah E Lamb, Peter Heine, and Mark Williams were not
involved in data extraction or ’Risk of bias’ assessment for their
own study (Lamb 2015); two other review authors (JB, NH-T)
carried this out.
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Measures of treatment effect
For continuous variables, a mean difference ( MD) or standard-
ised mean difference ( SMD) with corresponding 95% con-
fidence interval ( CI) was expressed, depending on the simi-
larity of measurement scales. We calculated risk ratios ( RRs)
with corresponding 95% CIs for dichotomous variables. We
also calculated absolute percentage change, relative percentage
change from baseline, and number needed to treat for an ad-
ditional beneficial outcome ( NNTB) only when an outcome
showed a statistically significant difference. We calculated the
NNTB for continuous outcomes with the available minimal clin-
ically important difference ( MCID) values using the Codfish
calculator provided by the Cochrane Musculoskeletal Group (
musculoskeletal.cochrane.org).
Dealing with missing data
We undertook analysis with the available data. Where data were
missing from trial reports, we attempted to contact trial authors.
We planned to consider the potential impact of missing data on
the findings of the review in the interpretation of bias. Where
possible, we planned to calculate missing standard deviations from
other statistics such as standard errors, confidence intervals, or P
values, according to the methods recommended in the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011b).
Assessment of heterogeneity
We judged heterogeneity from both a clinical and a statistical per-
spective. We evaluated statistical heterogeneity using the Chi2 test
for trend and a graphical display of the data (funnel plot). We
quantified inconsistency across studies using the I2 statistic, which
we interpreted as follows: 0% to 40% might not be important;
30% to 60%may represent moderate heterogeneity; 50% to 90%
may represent substantial heterogeneity; 75% to 100% consider-
able heterogeneity (Deeks 2011).
We judged clinical heterogeneity on the basis of the similarities
between study participants, exercise protocols, and outcome mea-
sures. If there was moderate heterogeneity (Chi2 P < 0.05 and I
2 value > 30%), we planned to use a random-effects model. We
combined data using a fixed-effect model if there was no clinical
and no important statistical heterogeneity (I2 < 40%).
Assessment of reporting biases
To assess the potential for reporting bias, we determined whether
the protocol of the randomised controlled trial was published be-
fore recruitment of participants had begun. For trials published
after 1 July 2005, we screened the World Health Organization
International Clinical Trials Registry Platform ( WHO ICTRP) (
apps.who.int/trialsearch). We reported the potential for selective
reporting of outcomes in the ’Risk of bias’ assessment.We planned
to explore publication bias with funnel plots if 10 or more studies
were available (Sterne 2011).
Data synthesis
Where appropriate, we performed meta-analysis. For analysis of
continuous data, we usedmean difference and a fixed-effect model
as the default. For dichotomous data, we planned to calculate risk
ratios using a fixed-effect model. The Summary of findings for the
main comparison includes comments on the quality of the body of
evidence according to theGRADEapproach (Schünemann 2011).
Subgroup analysis and investigation of heterogeneity
Where the data allowed, we planned to perform subgroup analy-
sis to assess the effect of exercise type (resistance versus mobility);
intervention frequency (at least once per day versus other less fre-
quent); and intervention duration (< 3 months versus 12 months
or beyond).
Sensitivity analysis
If there were sufficient data, we planned to conduct sensitivity
analysis for our primary outcomes to assess the effect of bias (e.g.
by restricting the analysis to studies with low risk of selection bias
due to the use of adequate methods of allocation concealment).
Summary of findings table
We produced the Summary of findings for the main comparison
table using the GRADEPro software. The table lists the magni-
tude of effects of hand exercise and the quality of the available
evidence. We compared hand exercise to no-exercise, waiting list
or usual care in people with rheumatoid arthritis on the outcomes
mentioned below. We used the GRADE approach recommended
in the Cochrane handbook for systematic reviews of interventions to
evaluate the quality of the evidence.
1. Hand function.
2. Pain.
3. Hand impairment: power grip strength.
4. Hand impairment: pinch grip strength.
5. ACR50 response criteria.
6. Participant adherence.
7. Adverse events.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
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Results of the search
The search yielded 1335 records, of which 951 were non-duplicate
citations.We excluded 910 records on the basis of title and abstract
screening and retrieved the remaining 41 for full-text review. We
deemed seven randomised controlled trials eligible for inclusion
in the review. A flow diagram of the selection process is presented
in Figure 1.
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Figure 1. Flow diagram of search outcomes.
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Included studies
Contact with authors
We attempted to contact authors of all seven included studies
to retrieve information about study conduct, outcome measures,
information required to complete ’Risk of bias’ assessments, or
incomplete data. We received responses from authors of Cima
2013, Hoenig 1993, and Lamb 2015. The authors of two studies
provided details on study methods, outcomes, and further data
(Cima 2013; Lamb 2015). The authors of one study replied saying
they no longer had access to the requested data (Hoenig 1993).
Study design
The included studies were published between 1993 and 17 July
2017, and all were randomised controlled trials using two-, three-,
or four-arm comparisons. Two studies used a control intervention
of joint protection advice (in Lamb 2015 and O’Brien 2006), plus
optional functional splinting (in Lamb 2015). The remaining five
studies used a control intervention of no treatment with mainte-
nance of normal medication regimen. The studies were conducted
in outpatient or home settings in Brazil, South Africa, Sweden,
the UK, and the USA.
Participants
All studies included participants with a diagnosis of RA, although
only four studies reported using validated diagnostic criteria (either
American College of Rheumatology or American Rheumatism
Association) (Buljina 2001; Hoenig 1993; Lamb 2015; O’Brien
2006). Disease duration was specified as a selection criterion in
two studies (Buljina 2001; Dellhag 1992). In the six studies that
reported disease duration, this ranged from five to 14 years. Three
studies stipulated that medications should be stable on entry (
Hoenig 1993; Lamb 2015; O’Brien 2006).
The total number of participants within studies ranged from 20,
in Cima 2013, to 490, in Lamb 2015, and group sizes ranged
from 7, in Cima 2013, to 246, in Lamb 2015. The majority of
participants across studies were female (n = 655, 78%), with two
studies including solely female participants (Brighton 1993; Cima
2013). The age range of participants was 20 to 94 years, although
only four studies provided data on age range (Cima 2013; Hoenig
1993; Lamb 2015; O’Brien 2006).
Baseline disease activity measures were reported in the form of
erythrocyte sedimentation rate (ESR) in three studies (Brighton
1993; Buljina 2001; Lamb 2015), on swollen and tender joint
counts in four studies (Buljina 2001; Hoenig 1993; Lamb 2015;
O’Brien 2006), and on C-reactive protein (CRP) levels in one
study (Lamb 2015). Three studies also reported medication status
at or near baseline (Brighton 1993; Buljina 2001; Lamb 2015).
Lamb 2015 reported that over 90% of participants were being
treated with conventional, non-biologic disease-modifying an-
tirheumatic drugs (DMARDs) (e.g.methotrexate, hydroxychloro-
quine) or biologic DMARDs at baseline. Another study reported
on medication three months prior to the study, with the major-
ity of participants prescribed traditional DMARDs or steroids, or
both, alongside non-steroidal anti-inflammatory drugs (NSAIDs)
(Buljina 2001). All participants in Brighton 1993 were reported to
be having either gold salt injections or D-penicillamine together
with an anti-inflammatory drug.
Interventions
Types of exercises, exercise goals, numbers of repetitions, numbers
of sets, duration of the intervention, types of supervision, and
methods of exercise instruction were reviewed.
All seven studies evaluated different hand exercise interventions
(Table 1). Six studies evaluated hand exercise programmes involv-
ing a combination of different exercise types (e.g. strengthening,
stretching, and dexterity) (Brighton 1993; Buljina 2001; Cima
2013; Hoenig 1993; Lamb 2015; O’Brien 2006). Two of these
studies also had additional groups randomised to programmes of
the separate exercise types (Hoenig 1993; O’Brien 2006).
Brighton 1993 evaluated a combined daily exercise programme
of dexterity, stretching, and strengthening exercises compared to a
control of no exercises. Buljina 2001 evaluated a combined daily
exercise programme of stretching and strengthening exercises com-
pared to a waiting-list control. Cima 2013 evaluated a combined
exercise programme of stretching and strengthening exercises per-
formed five days per week compared to a control of no exercises.
Dellhag 1992 evaluated three different thrice-weekly exercise reg-
imens compared to no therapy treatments: stretching exercises
only, stretching exercises with a wax bath, and a wax bath only.
Hoenig 1993 evaluated three different daily interventions com-
pared to no exercises: stretching exercises only, strengthening exer-
cises only, and a combination of stretching and strengthening ex-
ercises and treatments. Lamb 2015 evaluated a combined daily ex-
ercise programme of strengthening and stretching exercises along
with joint protection education and advice compared to joint pro-
tection education and advice alone. O’Brien 2006 evaluated two
different daily interventions compared to joint protection educa-
tion: stretching and strengthening exercises and stretching exer-
cises alone.
Exercise supervision varied considerably from daily supervision
with a therapist for three weeks in Buljina 2001 to four years with
six-monthly check-ups in Brighton 1993. The majority of studies
relied on participants performing exercise programmes at home
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(Brighton 1993; Cima 2013; Hoenig 1993; Lamb 2015; O’Brien
2006).
Outcomes
Across the seven studies, outcomes were measured in 11 different
domains (hand function, pain, adverse events, hand impairment,
general function, disease activity, adherence, treatment satisfac-
tion, costs/cost-effectiveness, medication changes, and health-re-
lated quality of life). All studies measured hand impairment in
some form, although variation of measurement tools was wide.
Three studies measured hand function, all with different tools
(Dellhag 1992; Lamb 2015; O’Brien 2006). Length of follow-
up ranged from three weeks, in Buljina 2001, to four years, in
Brighton 1993, the most common endpoint being short term (i.e.
less than 3 months) (Buljina 2001; Cima 2013; Dellhag 1992;
Hoenig 1993). Medium-term outcomes were available from two
studies (Lamb 2015; O’Brien 2006). Only two studies reported
long-term outcomes (i.e. 12 months or beyond) (Brighton 1993;
Lamb 2015).
Excluded studies
Of the 41 studies retrieved for full-text review, most did not eval-
uate an exercise programme specific to RA of the hand (n = 18,
Azeez 2014; Baillet 2009; Bearne 2012; Berntzen 2016; Cakir
2014; Dash 2001; De Jong 2004; Flint-Wagner 2009; Hansen
1993; Kiraly 2015; Lineker 2001; Minor 1995; Orlova 2016;
Pineda-Juárez 2016; Pot-Vaucel 2016; Seneca 2015; Shapoorabadi
2016; Tee 2016), or did not compare an exercise programme to
a non-exercise comparator (n = 12, Brorsson 2014; Byers 1985;
Dogu 2013; Dulgeroglu 2014; Dülgero lu 2016; Hammond
2004a; Hawkes 1985; Hawkes 1986; Khedekar 2017; Piga 2014;
Srikesavan 2016; Veitiene 2004). Another reason for exclusion
was studies not using a randomised design (n = 4, Brorsson 2009;
Maxwell 2005; Rapoliene 2006; Ronningen 2008).
Risk of bias in included studies
Full details of risk of bias for the seven included studies are available
in the ’Risk of bias’ tables (see Characteristics of included studies),
and a summary is presented in Figure 2. We considered no studies
to be at low risk of bias for all of the eight defined categories,
although we judged two studies to be at low risk for all categories
apart fromblinding of participants and therapy personnel, which is
likely to be the best scenario that can be achieved for these types of
interventions (Lamb 2015; O’Brien 2006). The remaining studies
varied in their risk of bias across categories.
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Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
Random sequence generation
Five studies were at low risk of bias for sequence generation (
Buljina 2001; Cima 2013; Hoenig 1993; Lamb 2015; O’Brien
2006): two studies used a random number table (Buljina 2001;
Hoenig 1993), and three studies employed a computer-generated
randomisation list (Cima 2013; Lamb 2015; O’Brien 2006).
Two studies did not provide sufficient details of the method used
and were therefore considered to be at unclear risk of bias for
sequence generation (Brighton 1993; Dellhag 1992).
Allocation concealment
Only two studies provided details of their allocation procedure;
we considered these to be at low risk of bias (Lamb 2015; O’Brien
2006). The remaining studies did not provide any information as
to whether the allocation was concealed and were considered to
be at unclear risk of bias for allocation concealment.
Blinding
Participants
We judged all seven included studies to be at high risk of bias due
to lack of blinding of participants.
Study personnel
We judged six studies to be at high risk of bias due to lack of
blinding of personnel. In one study (Hoenig 1993), participants
were instructed in all exercise programmes and then informed in
writing which programme to continue. Therapists were therefore
blinded to which intervention the participant received, hence this
studywas considered to be at low risk of bias for therapist blinding.
However, this solution raises another potential source of bias in
the form of treatment contamination.
Outcome assessment
All studies except Brighton 1993 that measured self reported out-
comes were at high risk of detection bias, as participants were
not blinded to self reported outcomes assessment. We judged
four studies to be at low risk of detection bias, as they reported
blinded assessors for measuring objective outcomes (Brighton
1993; Hoenig 1993; Lamb 2015; O’Brien 2006). In two stud-
ies the risk of bias was unclear (Buljina 2001; Dellhag 1992). In
Cima 2013, the assessor and therapists were not blinded as they
were involved in both the assessment and evaluation, though not
the analysis. We therefore deemed this study as at high risk for
detection bias.
Incomplete outcome data
We assessed three studies as at low risk of bias for this domain
(Cima 2013; Lamb2015;O’Brien2006).O’Brien2006 andLamb
2015 used intention-to-treat analysis, and Lamb 2015 investigated
the effects of missing data. Following our obtaining unpublished
data and rationale for dropouts, we also considered Cima 2013 to
be at low risk of bias. We considered three studies as at unclear
risk of bias (Brighton 1993; Buljina 2001; Dellhag 1992). We
judged Hoenig 1993 as at high risk of bias as the dropouts had
RA for a significantly longer period of time, and the analysis also
excluded non-compliant participants and those with changes to
medication.
Selective reporting
We rated five studies as at low risk of bias (Buljina 2001; Cima
2013; Dellhag 1992; Lamb 2015; O’Brien 2006). Two studies
reported measuring outcomes but failed to present correspond-
ing data (Brighton 1993; Hoenig 1993). Brighton 1993 failed to
present any data on intermediate outcome time points between
baseline and four years, and Hoenig 1993 failed to report on the
global assessment of arthritis severity, so we judged both of these
studies as at high risk of bias.
Other potential sources of bias
We judged the majority of studies to be balanced at baseline
(Buljina 2001; Dellhag 1992; Lamb 2015; O’Brien 2006). The
Cima 2013 study presented no baseline characteristics other than
participant age, and Brighton 1993 made no reference to the com-
parability of participant baseline characteristics between groups.
The Hoenig 1993 control group had a higher baseline function in
the left hand.
Two studies did not declare their funding sources (Brighton 1993;
Buljina 2001). We deemed there to be a risk of treatment contam-
ination bias in the Hoenig 1993 study, as all three exercise regi-
mens were demonstrated to all participants, and then they were
instructed remotely to only carry out one of the exercise regimens
they had been taught.
Effects of interventions
See: Summary of findings for the main comparison Exercise
compared to no exercise for rheumatoid arthritis of the hand
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See Summary of findings for the main comparison for the main
comparison.
Major outcomes
Hand function
Three studies evaluated hand function (Table 2) (Dellhag 1992;
Lamb 2015; O’Brien 2006). Dellhag 1992 clinically assessed hand
grip function of the dominant hand using the Sollerman grip func-
tion test; Lamb 2015 used the Michigan Hand Outcome Ques-
tionnaire (MHQ) overall hand function subscale; and O’Brien
2006 used the Arthritis Impact Measurement Scale 2 (AIMS 2)
hand function subscale. Lamb 2015 assessed hand function at 4
and 12 months, whilst the other studies did not evaluate the long-
term effects of exercise on hand function.
Dellhag 1992 reported no statistically significant differences be-
tween groups for Sollerman grip function scores at four weeks. The
exercise group (n = 11) measured 76.1 points, while the no-treat-
ment control group (n = 13) measured 75 points on the Sollerman
grip function test scale of 0 to 80 points (higher scores mean better
grip function). We could not meta-analyse the results from this
study due to insufficient reporting of data.
Two studies reported hand function outcomes in themedium term
(Lamb 2015; O’Brien 2006). Raw scores were only available for
Lamb 2015 (n = 490), and O’Brien 2006 presented change scores
on the AIMS 2 scale. The change in hand and finger function of
the AIMS scale (0 to 10, higher scores mean more difficulty) from
baseline to 6months in the exercise group (n = 18) was 0.97 (1.72)
and in the control group (n = 18), which received joint protection
advice, 0.38 (1.68), P = 0.414 (O’Brien 2006).
Figure 3 (Analysis 1.1) presents the forest plot for the results from
Lamb 2015. Compared to usual care (joint protection education,
general exercise advice, and functional splinting), exercise in addi-
ton to the usual care improved hand function (both hands) in the
medium term (mean difference (MD) 4.5 points, 95% confidence
interval (CI) 1.58 to 7.42; n = 449) and in the long term (MD4.3,
95% CI 0.86 to 7.74; n = 438). In the medium term, the absolute
percentage change on the 0-to-100 overall hand function subscale
of the MHQ (higher scores mean better hand function) was 5%
(95% CI 2% to 7%); relative percentage change 9% (95% CI 3%
to 14%); and number needed to treat for an additional beneficial
outcome (NNTB) 8 (95% CI 5 to 20). In the long term, the ab-
solute percentage change was 4% (95% CI 1% to 8%); relative
percentage change 8% (95% CI 2% to 15%); and NNTB 9 (95%
CI 6 to 27). Based on the MCID of 13 points for MHQ overall
hand function in RA (Shauver 2009), a 4% to 5% absolute im-
provement on a 0-to-100 scale suggests a minimal clinical benefit.
Figure 3. Forest plot of comparison: 1 Exercise versus control, outcome: 1.1 Hand function as measured by
the Michigan Hand Outcomes Questionnaire.
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The same study, Lamb 2015, conducted an extended follow-up on
hand function outcome (Williamson 2017). The mean follow-up
time was 26 months (range 19 to 40 months), and there was
no difference in change in hand function from baseline between
the two groups (MD 1.52, 95% CI -1.71 to 4.76; n = 328). As
these data were collected through postal questionnaires and did
not represent the primary endpoint of the trial, we did not include
them in the analysis.
Pain
Four studies evaluated pain (Buljina 2001; Dellhag 1992; Hoenig
1993; Lamb 2015). Hoenig 1993 did not report pain results.
Two studies reported the effects of exercise on pain intensity in
the short term and found statistically significant improvements
in favour of hand exercise (Buljina 2001; Dellhag 1992). Figure
4 presents the forest plot for the results from Buljina 2001 and
Dellhag 1992. The results indicated that exercise compared to
waiting list or no treatment reducedpain intensity in the short term
(MD -27.98, 95%CI -48.93 to -7.03; n = 124). The absolute per-
centage change on 0-to-100-millimetre scale (higher scores mean
more pain) was -28% (95% CI -49% to -7%); relative percentage
change -41% (95% CI -72% to -10%); and NNTB 2 (95% CI
2 to 11). Although the difference between groups exceeded the
MCID of 10 mm of pain (Kitchen 2013), these findings should
be interpreted with caution as both studies were downgraded for
risk of bias and imprecision.
Figure 4. Forest plot of comparison: 1 Exercise versus control, outcome: 1.2 Pain.
One large study, Lamb 2015, showed a non-significant decrease
in pain intensity in the exercise group compared to usual care in
the medium term (MD -2.8, 95% CI -6.96 to 1.36; n = 445)
(Figure 4; Analysis 1.2), with an absolute percentage change of
-3% (95% CI -7% to 2%) and relative percentage change -5%
(95% CI -14% to 3%) on 0-to-100 pain subscale of the MHQ
(higher scores mean more pain). The same study indicated a non-
significant decrease in pain in the exercise group compared to usual
care in the long term (MD -3.7, 95% CI -8.1 to 0.7; n = 437)
(Figure 4; Analysis 1.2); absolute percentage change -4% (95%
CI -8% to 1%); and relative percentage change -7% (95% CI -
15% to 1%). The NNTB was not applicable as results were non-
significant.
Lamb 2015 also reported pain intensity scores adjusted for centre,
sex, age, and medication type (Table 3). The mean treatment dif-
ferences in the medium and long term were -3.30 (95% CI -6.50
to -0.11) and -2.40 (95% CI -5.92 to 1.12), respectively.
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Hand impairment measures (power grip strength and pinch
grip strength)
Power grip strength (gross grip)
All seven studies investigated the effect of exercise on power grip
strength. Three studies found statistically significant differences
between groups in favour of exercise (Brighton 1993; Buljina
2001; Cima 2013), whilst the remaining four studies found no
statistically significant differences between groups (O’Brien 2006;
Dellhag 1992; Hoenig 1993; Lamb 2015). In Dellhag 1992, at
four weeks, the maximal grip strength of the dominant hand was
126.2 N in the exercise group (n = 11) and 105.9 N in the no-
treatment control group (n = 13). Themaximal grip strength of the
non-dominant hand was 145.1 N in the exercise group and 120.3
N in the control group. The average grip strength of the dominant
hand was 109.7 N in the exercise group and 85.4 N in the control
group. The average grip strength of the non-dominant hand was
108N in the exercise group and99.9N in the control group.There
were no significant differences in the maximum or average grip
strength of dominant and non-dominant hands between groups.
We pooled data from three studies that reported effects of exercise
on power grip strength in the short term (Buljina 2001; Cima
2013; Hoenig 1993). Lamb 2015 provided medium- and long-
term outcomes. We could not pool other studies due to lack of
data or incompatible measures.
Figure 5 (Analysis 1.3) presents the forest plot for the results for
Buljina 2001, Cima 2013, and Hoenig 1993 (n = 141). Com-
pared to waiting list or no treatment, exercise improved power
grip strength in the short term. For the left hand, the standard-
ised mean difference (SMD) was 0.44 (95% CI 0.11 to 0.78) re-
expressed to an equivalent improvement of 3.5 kg (95% CI 0.87
to 6.1), and the relative percentage change was 24% (95% CI 6%
to 42%). For the right hand, the SMD was 0.46 (95% CI 0.13
to 0.8) re-expressed to 4 kg (95% CI 1.13 to 7), and the relative
percentage change was 26% (95% CI 7% to 45%).
Figure 5. Forest plot of comparison: 1 Exercise versus control, outcome: 1.3 Hand impairment - power grip
strength: short term (< 3 months).
Lamb 2015 provided data for medium- and long-term power grip
strength Figure 6 (Analysis 1.4). The study provided mean power
grip strength data of both hands in newtons, which were con-
verted to kilograms for analysis. Compared to usual care, the exer-
cise group showed a non-significant increase in mean power grip
strength of both hands in the medium term (MD 1.4 kg, 95%
CI -0.27 to 3.07; n = 400); relative percentage change 11% (95%
CI -2% to 13%), and in the long term (MD 1.2 kg, 95% CI -
0.62 to 3.02; n = 355); relative percentage change 9% (95% CI -
23Exercise for rheumatoid arthritis of the hand (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
5% to 23%). Absolute percentage change and NNTB are not ap-
plicable for lack of scale with maximum limit and non-significant
outcomes.
Figure 6. Forest plot of comparison: 1 Exercise versus no exercise, outcome: 1.4 Hand impairment - power
grip strength: medium and long term.
In O’Brien 2006, the change in gross grip strength of the domi-
nant hand from baseline to 6 months in the exercise group (n =
18) was 9.7 lbs (11.5) and in the control group (n = 18), which
received joint protection advice, was 3.4 lbs (21.32) (P = 0.300).
Brighton 1993 provided grip strength data measured in mmHg.
The study reported that there was a statistically significant im-
provement in grip strength in the exercise group compared to the
control group, which did not receive exercises, over the four-year
period. The mean grip strength in the exercise group (n = 19) was
105.7 mmHg and in the control group (n = 25) was 44.1 mmHg
at 48 months. We could not meta-analyse results from this study
due to insufficient reporting of data.
Pinch grip strength (tip-to-tip/tripod pinch)
Five studies investigated effect of hand exercise on pinch grip
strength (Brighton 1993; Buljina 2001; Cima 2013; Lamb 2015;
O’Brien 2006). These studies assessed different types of pinch
grips and all found statistically significant differences in favour of
hand exercise. Two studies provided data that could be pooled for
short-term outcome (Buljina 2001; Cima 2013).
Data from Buljina 2001 and Cima 2013 (n = 120) indicated that
compared towaiting list or no treatment, exercise improved tip-to-
tip pinch grip strength in the short term Analysis 1.5 . For the left
hand, the MD was 0.51 kg (95% CI 0.13 to 0.9); relative change
44% (95% CI 11% to 78%), and for the right hand, the MD was
0.82 kg (95%CI 0.43 to 1.21); relative change 68% (95%CI 36%
to 101%). Lamb 2015 provided data for medium- and long-term
pinch grip strength. The study provided data asmean tripod pinch
grip strength of both hands in newtons, which were converted to
kilograms for analysis. Compared to usual care, the exercise group
showed a non-significant increase in mean pinch grip strength of
both hands in the medium term (MD 0.3 kg, 95% CI -0.14 to
0.74; n = 396); relative percentage change 8% (95% CI -4% to
19%), and in the long term (MD 0.4 kg, 95% CI -0.08 to 0.88;
n = 351); relative percentage change 10% (95% CI -2% to 22%).
Absolute percentage change andNNTB are not applicable for lack
of scale with maximum limit and non-significant outcomes.
In O’Brien 2006, the change in key grip strength of the dominant
hand from baseline to 6 months in the exercise group (n = 18) was
1 lb (2.97) and in the control group (n = 18), which received joint
protection advice, was -1 lb (2.45) (P = 0.014).
Brighton 1993 provided pinch strength data measured in mmHg.
The study reported that there was a statistically significant im-
provement in pinch strength in the exercise group compared to the
control group, which did not receive exercises, over the four-year
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period. The mean grip strength in the exercise group (n = 19) was
54.8 mmHg and in the control group (n = 25) was 24.8 mmHg
at 48 months. We could not meta-analyse results from this study
due to insufficient reporting of data.
ACR50 response
None of the studies reported disease activity ACR50 responder
criteria.
Participant adherence
Only one study Lamb 2015 reported participant adherence rates
for treatment attendance and subsequent unsupervised exercise ad-
herence Analysis 1.6. Seventy-five per cent of exercise programme
participants (n = 246) attended the full number of six supervised
exercise sessions compared to 93% of usual care participants (n
= 242) who attended the full number of sessions (a maximum of
three).
Exercise adherence was measured using a five-item self reported
exercise behaviour questionnaire. At four months, 174/216 (81%)
of the exercise group participants self reported more than 1 to
2 unsupervised exercise sessions per week compared to 137/222
(62%) of the participants who received usual care alone. The risk
ratio was 1.31 (95% CI 1.15 to 1.48) and NNTB 6 (95% CI 4
to 10). At 12 months, 128/206 (62%) of the participants who
received hand exercises with usual care self reported more than 1
to 2 unsupervised exercise sessions per week compared to 123/216
(57%) of the participants who received usual care alone. The risk
ratio was 1.09 (95% CI 0.93 to 1.28). Number needed to treat
for an additional beneficial outcome was not applicable as results
were not significant.
In the extended follow-up of Lamb 2015, 31% of the exer-
cise group participants (48/155) reported that they exercised
at least three times a week compared to 35% of the control
group participants (60/173), showing no between-group differ-
ences (Williamson 2017). As these data did not represent the pri-
mary endpoint of the trial and were collected through postal ques-
tionnaires, we did not include them in the analysis.
Adverse events
Only one studymeasured this outcome (Lamb2015), which found
that no adverse events related to exercising were reported when
246 exercise therapy group participants were followed up for one
year.
Minor outcomes
Hand impairment (range of motion, dexterity, deformity,
and hand stiffness)
Range of motion
All studies except Cima 2013 evaluated hand range of motion
as an outcome. We were unable to pool data due to deficiencies
in reporting for the majority of studies. Two studies found no
statistically significant differences between groups (Hoenig 1993;
O’Brien 2006); two studies found inconsistent between-group dif-
ferences (Dellhag 1992; Lamb 2015); one study found a statis-
tically significant difference between groups (Buljina 2001); and
another study failed to present between-group analyses (Brighton
1993).
Dexterity
Two studies evaluated the effect of hand exercise on dexterity
(Hoenig 1993; Lamb 2015). Lamb 2015 found that there was a
statistically significant difference between groups, with improved
dexterity in the exercise group compared to usual care at 12
months, whereas Hoenig 1993 found no statistically significant
difference between groups. We were unable to pool data due to
lack of data from one study (Hoenig 1993).
Deformity
Two studies evaluated the effect of hand exercise on hand defor-
mity (Hoenig 1993; Lamb 2015). Lamb 2015 used goniomet-
ric measurement of metacarpophalangeal ulnar/radial deviation
in maximum pronation position, while Hoenig 1993 measured
degree of ulnar deviation of the third digit with a goniometer.
Hoenig 1993 also used clinician rating of hand deformity, which
was not reported. Both studies found no statistically significant
differences between groups. We were unable to pool data due to
lack of data from one study (Hoenig 1993).
Hand stiffness
Three studies reported hand stiffness (Brighton 1993; Dellhag
1992; Hoenig 1993), although only one, Dellhag 1992, presented
results, therefore we were unable to pool the data. Two studies
found no statistically significant differences between groups.
General function
Three studies evaluated the effect of hand exercise on general func-
tion, two for short-term outcome (Buljina 2001; Cima 2013),
and one for medium- and long-term outcomes (Lamb 2015). We
pooled data (Analysis 1.7) from two studies (Buljina 2001; Cima
2013), finding a positive effect of hand exercise on function in
the short term (SMD 0.79, 95% CI 0.42 to 1.17; n =120). Lamb
2015 found a larger effect on general function at medium term
in those who received hand exercise (SMD 1.45, 95% CI 1.24 to
1.66; n = 449). There was considerable heterogeneity among the
data at different time points (Chi2 P = 0.003, I2 = 89%), and so
it was not appropriate to present a pooled estimate.
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Disease activity
Tender and swollen joints
Four studies evaluated the effect of hand exercise on swollen and
tender joint counts (Buljina 2001; Hoenig 1993; Lamb 2015;
O’Brien 2006).We pooled onlymedium-term outcome data from
two studies, Lamb 2015 and O’Brien 2006, due to incomplete
data reporting by the other two studies. We used an SMD analysis
due to variation in the numbers of joints counted. O’Brien 2006
evaluated the whole body as recommended by European League
Against Rheumatism, whilst Lamb 2015 used a modified joint
count of the hand and wrists only. We found a small positive
effect in favour of hand exercise in the medium term for swollen
joint counts (MD -0.16, 95% CI -0.34 to 0.01; n = 492) and
tender joint counts (SMD -0.19, 95% CI -0.37 to -0.01; n = 492)
(Analysis 1.8).
Other measures of disease activity
Othermeasures of disease activity were used but were not reported
consistently enough for data pooling. These included the blood
tests for erythrocyte sedimentation rate (ESR) (Buljina 2001;
Lamb 2015), C-reactive protein (CRP) levels (Lamb 2015), and
proximal interphalangeal joint swelling (Buljina 2001; Hoenig
1993). No statistically significant differences between groups were
found for these outcomes in individual studies (Buljina 2001;
Hoenig 1993; Lamb 2015).
Patient satisfaction
One study reported outcomes of patient satisfaction using two
measures (Lamb 2015). At 12 months after treatment, partici-
pants in the exercise group had higher MHQ satisfaction scores
compared to the control group (MD 3.76, 95% CI -0.02 to 7.54;
n = 436), and patient satisfaction was significantly higher for those
receiving exercise therapy (Wilcoxon test, P < 0.0001).
Costs
One study reported costs of interventions and results of cost-ef-
fectiveness analyses (Lamb 2015), finding that the cost of exercise
was GBP 103, 95% CI GBP -622 to GBP 838 higher than usual
care. Quality-adjusted life year (QALY) gains were 0.01, 95% CI -
0.03 to 0.05 in favour of hand exercise treatment, translating into
an incremental cost per QALY gain of GBP 9549.
Change in splint or assistive device usage
No trials reported rates of change in splint or assistive devices.
Subgroup and sensitivity analyses
Data did not allow for valid subgroup analyses to assess the effects
of exercise type, intervention frequency, or intervention duration
on treatment effect, or sensitivity analyses for effect of bias.
Assessment of reporting bias
Only one study published a protocol of the study prior to publi-
cation of results (Lamb 2015). There was not a sufficient number
of studies to warrant exploration of publication bias with funnel
plots (Sterne 2011), so our assessment of selective reporting was
limited to comparing reporting in methods and results sections of
publications.
D I S C U S S I O N
Summary of main results
We set out to determine the benefits and harms of hand exercise for
people with rheumatoid arthritis. We included seven studies with
841 participants. The findings of the review were driven by one
large multicentre study conducted in the UK, which contributed
58% of participants (Lamb 2015, n = 490). The heterogeneity
of outcomes used and the quality of reporting of data limited
the pooling of results. In addition, most included studies only
evaluated short-term effectiveness.
Of the three studies that evaluated hand function (Dellhag 1992;
Lamb 2015; O’Brien 2006), Dellhag 1992 did not find significant
differences in favour of exercise in the short term. Exercise probably
slightly improves hand function with a minimal clinical benefit in
the medium and long term (Lamb 2015).
Two small studies showed that exercise has a beneficial effect on
pain in the short term. Lamb 2015 showed that there is probably
little or no difference on pain with exercise when compared to
usual care in the medium and long term.
The most commonly evaluated outcomes were of impairments.
All studies measured power grip strength, but we could only pool
data from three small studies, resulting in improvements in favour
of exercise on power grip strength and pinch grip strength in the
short term. Whether these levels of effect are clinically important
remains unclear. Lamb 2015 showed that there is little or no dif-
ference on improving power grip and pinch grip strength with ex-
ercise when compared to usual care in the medium and long term.
No studies evaluated ACR50 criteria.
In the medium term, people who received hand exercise delivered
with behavioural support strategies for exercise adherence (e.g.
exercise diary, goal setting, action planning) along with usual care
were more likely to be adherent than those who did not receive
exercise. There was little or no difference between groups in the
long term.
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In Lamb 2015, the only study that reported on safety, no adverse
events were attributed to exercises.
Findings for range of motion and dexterity were the most incon-
sistent of any outcome, whereas there was greater clarity that ex-
ercise did not influence deformity or self reported stiffness. With
regard to disease activity, as measured by the number of swollen
and tender joints, there appeared to be a small positive effect in the
medium term as evidenced by two studies (Lamb 2015; O’Brien
2006). Lamb 2015 provided outcome data on a multitude of con-
structs and was the only study to investigate and report on the im-
portant issues of participant adherence, patient satisfaction, and
cost-effectiveness of exercise. These are important outcomes to in-
vestigate in future studies.
Overall completeness and applicability of
evidence
The evidence included and synthesised in this review was largely
driven by the findings from one multicentre study (Lamb 2015).
Overall, the evidence ranged from ’very low’ to ’high’ across major
outcomes. Heterogeneity of interventions and outcome measures,
methodological limitations, risk of bias, and poor reporting or lack
of data were barriers for determining the quality of the evidence.
The study populations appeared to be representative of patients
seen in outpatient or home settings in Brazil, South Africa, Swe-
den, the UK, and the USA, and there was a greater inclusion of
females (78%) in the studies that were reviewed. We found fre-
quency of the interventions to be fairly consistent, with most stud-
ies prescribing a daily exercise programme with varying levels of
supervision. The duration of interventions was much more vari-
able, ranging from just a few weeks with daily supervision to four
years. The evidence derived from the included studies does not
allow conclusions to be drawn about which format is best in terms
of frequency and supervision. Disease duration ranged from five
to 14 years, which may be considerably longer than therapists are
used to now seeing. Future studies should make an effort to eval-
uate effectiveness at different stages of the disease and if possible
to ascertain the optimum point at which to start exercising.
Quality of the evidence
Hand function
For short-term hand function, we downgraded the quality of evi-
dence from Dellhag 1992 three levels to ’very low’ due to risk of
bias (unclear risk of selection bias, high risk of performance bias,
unclear risk of detection bias in measuring objective hand func-
tion, unclear risk of attrition bias) and imprecision (sample size
less than 400). We are therefore uncertain as to whether exercise
has a beneficial effect on hand function in the short term.
For medium- and long-term hand function, we downgraded the
quality of evidence from Lamb 2015 one level to ’moderate’ due
to risk of bias (high risk of performance and detection biases in
measuring self reported hand function). Exercise therefore proba-
bly slightly improves hand function in themedium and long term.
Further research is likely to have an important impact on our con-
fidence in the estimate of effect and may change the estimate.
Pain
For short-term pain, we downgraded the quality of evidence from
Buljina 2001 and Dellhag 1992 three levels to ’very low’ due to
risk of bias (unclear risk of selection bias, high risk of performance
and detection biases in measuring self reported pain, unclear risk
of attrition bias) and imprecision (sample size less than 400). We
are therefore uncertain as to whether exercise reduces pain in the
short term.
For medium- and long-term pain, we downgraded the quality of
evidence from Lamb 2015 one level to ’moderate’ due to risk of
bias (high risk of performance and detection biases in measuring
self reported pain). Exercise therefore probably has little or no
difference on pain in the medium and long term. Further research
is likely to have an important impact on our confidence in the
estimate of effect and may change the estimate.
Power grip strength
For short-term power grip strength, we downgraded the quality of
evidence from Buljina 2001, Cima 2013, and Hoenig 1993 three
levels to ’very low’ due to risk of bias (unclear risk of selection bias,
high risk of performance bias, unclear or high risk of detection
bias in measuring objective grip strength, unclear or high risk of
attrition bias) and imprecision (sample size less than 400). We are
therefore uncertain as to whether exercise improves power grip
strength in the short term.
For medium- and long-term power grip strength, we graded the
quality of evidence fromLamb 2015 as ’high’, as we considered the
risk of performance bias with objectively measured grip strength
not a significant reason for downgrading the evidence. Exercise
therefore has little or no difference on mean power grip strength
of both hands in the medium and long term. Further research is
very unlikely to change our confidence in the estimate of effect.
Pinch grip strength
For short-term pinch grip strength, we downgraded the quality of
evidence from Buljina 2001 and Cima 2013 three levels to ’very
low’ due to risk of bias (unclear risk of selection bias, high risk of
performance bias, and unclear or high risk of detection bias) and
imprecision (sample size less than 400).We are therefore uncertain
as to whether exercise improves pinch grip strength in the short
term.
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For medium- and long-term pinch grip strength, we graded the
quality of evidence fromLamb 2015 as ’high’, as we considered the
risk of performance bias with objectively measured pinch strength
not a significant reason for downgrading the evidence. Exercise
therefore has little or no difference on mean pinch grip strength
of both hands in the medium and long term. Further research is
very unlikely to change our confidence in the estimate of effect.
Participant adherence
Wedowngraded the quality of evidence fromLamb 2015 one level
to ’moderate’ due to risk of bias (high risk of performance and
detection biases in measuring self reported participant adherence).
This evidence suggests that people who received hand exercises
with behavioural support strategies along with usual care were
more adherent than those who received usual care alone in the
medium term, but there was not much difference between groups
in the long term. Further research is likely to have an important
impact on our confidence in the estimate of effect andmay change
the estimate.
Adverse events
Wedowngraded the quality of evidence fromLamb 2015 one level
to ’moderate’ due to risk of bias (high risk of performance and
detection biases in measuring self reported adverse events). This
evidence suggests no adverse events were reported in people who
received hand exercises with behavioural support strategies along
with usual care. Further research is likely to have an important
impact on our confidence in the estimate of effect andmay change
the estimate.
Potential biases in the review process
The main limitations of the review process were the paucity of
appropriate data that were necessary for meta-analysis, and the
variation in outcome measures used. Most of our attempts to con-
tact study authors were unsuccessful, and therefore the majority
of data has come from published data. Only one study published
a protocol prior to conduct of the study (Lamb 2015), making it
difficult to assess selective outcome reporting. This also demon-
strates a clear need for future studies to publish a protocol prior to
conduct of the study in order to improve assessment of reporting
bias. We were unable to perform formal assessment of publication
bias of the included studies due to data limitations. Several reviews
have used the Cochrane ’Risk of bias’ tool, which is recognised to
have limited reliability (Armijo-Olivo 2014; Hartling 2013).
There was wide variation in the details of the evaluated interven-
tions, with no two studies being truly alike. This is a commonly
cited flaw of pooling data for meta-analysis, and a reason why we
have restricted the meta-analysis to very few cases where the clin-
ical heterogeneity appears to be acceptably low. If, as we believe,
function of the hand and wrist is of primary interest for exer-
cise interventions, and coupled with the fact that it is impossible
to blind participants to allocation, care needs to be taken when
recording self report measures and the inherent risk of bias this
brings. It is therefore important to evaluate effects at an ’objective’
impairment level simultaneously to check the signal is consistent.
Agreements and disagreements with other
studies or reviews
In 2004, Wessel conducted a narrative review of nine English-lan-
guage only randomised and non-randomised studies published up
to 2003, including four of the seven studies in this review (Wessel
2004). Wessel concluded that there was little evidence to support
or refute hand exercise. Since this time only one other systematic
review has been published (Bergstra 2014), which drewmore posi-
tive conclusions about the effectiveness of exercise on the RAhand.
Bergstra 2014 included eight randomised and non-randomised
studies and inferred that grip strength and function were consis-
tently improved, but changes for range of motion were incon-
sistent. The conclusions from our review differ slightly, showing
moderate evidence for small beneficial effects on hand function,
but little or no effect on grip strength in the medium and long
term. Our review is the only review to include only randomised
trials assessing the effectiveness of hand exercises in RA. No re-
views prior to this have attempted a meta-analysis.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
The results of this review indicate that it is uncertain whether ex-
ercise improves hand function in the short term. Exercise proba-
bly improves hand function with a minimal clinical benefit in the
medium and long term. It is uncertain whether exercise improves
pain in the short term, and it probably has little or no difference
in the medium and long term. It is uncertain whether exercise
improves power grip strength and pinch grip strength in the short
term, but shows little or no difference on these outcomes in the
medium and long term. The effects of hand exercise on American
College of Rheumatology 50 (ACR50) response criteria are un-
known. In the medium term, people who received hand exercise
with behavioural support strategies for adherence in addition to
routine care were probably more adherent than those who received
routine care alone, however there was little or no difference be-
tween groups in the long term. Exercise seems to be safe without
any adverse effects.
Implications for research
Given our conclusions that the current evidence is based on studies
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with variable quality, it is clear that further studies of high quality
in conduct and reporting are warranted to evaluate the effective-
ness of exercise therapy for the rheumatoid arthritis hand. Cer-
tainly, the development of a core set of outcomes for conservative
treatments for rheumatoid arthritis would improve the ability to
synthesise evidence in this and similar areas. Studies need to be
clear in their reporting of the primary outcome of interest; we
suggest that function of the hand and wrist is most appropriate.
Going one step further, research to ascertain the clinically impor-
tant change in hand function is also required.
Another important issue in improving upon existing reporting of
trials of exercise therapy is how authors should attempt to de-
fine, control, and report dosage of exercise and related adherence
in accordance with the template for intervention description and
replication (TIDieR) guidelines (Hoffman 2014). Incorporating
different, evidence-based behavioural support strategies for adher-
ence and evaluating their impact on long-term adherence is also
an important area to be explored. With the majority of the studies
included in this review evaluating short-term effectiveness, there is
a need for incorporating evaluation of long-term effectiveness, es-
pecially for a chronic health condition such as rheumatoid arthri-
tis. Finally, we have already highlighted that we are unable to rec-
ommend one exercise programme over another with any certainty.
Future research to evaluate the efficacy of different modes of exer-
cise intensity, frequency, and duration would therefore be a wel-
come addition to the evidence base.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Brighton 1993
Methods RCT
Participants 55 female participants (25 intervention group, 30 control group) with active rheuma-
toid arthritis for at least 1 year (ESR > 25), aged > 18 years (range 27 to 61 years),
housewives or sedentary occupation, RF positive, erosions present inMCPs and/or PIPs,
Steinbrocker functional class I, all on either gold injections or D-penicillamine plus anti-
inflammatories
Country: South Africa
Interventions Intervention group: daily home exercise programme consisting of range of motion and
strengthening exercises for 48 months, 6-monthly checks with reinforcement
Control group: no treatment
Outcomes Grip strength (sphygmomanometer, mmHg, higher score = greater strength)
Pincer grip strength (sphygmomanometer, mmHg, higher score = greater strength)
MCP and PIP total ROM score (goniometer, degrees, sum of flexion and extension
ROM of all fingers, higher score = greater movement)
Outcome time points: baseline; 4 years
Notes Source of funding not declared.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “The patients were divided into two groups by random
allocation”; however, details regarding randomisation method
unclear
Allocation concealment (selection bias) Unclear risk No method described.
Blinding of participants
All outcomes
High risk Not possible
Blinding of personnel
All outcomes
High risk Not possible
Blinding of outcome assessment (detection
bias)
Self-reported outcomes
Unclear risk Participants were aware of treatment allocation. No subjective
outcome measures used
Blinding of outcome assessment (detection
bias)
Objective outcomes
Low risk Quote: “All the patients were examined by the same examiner
unaware of which patient was in the test or control group”
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Brighton 1993 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No explanation given for withdrawals and how theywere treated
in analysis
Selective reporting (reporting bias) High risk No information on data from interim follow-up assessments
Other bias Unclear risk No description of baseline characteristics of 2 groups other than
age
Buljina 2001
Methods RCT
Participants 100 participants (50 intervention group, 50 in control group) with rheumatoid arthritis
according to ACR criteria; years since diagnosis 6 months to 22 years; 25male, 75 female;
age range 20 to 67 years; ESR > 25; ≥ 3 swollen joints in both hands; ≥ 5 tender joints
in both hands; decreased ROM and grip
Country: USA
Interventions Intervention group: daily radon bath plus faradic hand bath plus wax bath plus a hand
exercise programme (Flatt’s range of motion and strengthening exercises for 3 weeks as
an inpatient in rehabilitation facility
Control group: waiting-list control
Outcomes ESR (mm in first hour - Westergren method, higher score = greater disease activity)
PIP joint size (arthrocircometer, mm, higher score = greater swelling)
Joint tenderness (Ritchie articular index, higher score = greater disease activity)
Hand pain (0-to-100 VAS, higher score = greater pain)
Jointmobility ofMCPs, PIPs andwrist of dominant hand (goniometer, degrees converted
to a 0-to-10 scale, greater score = better ROM)
Grip strength (Jamar dynamometer, kg, higher score = greater strength)
Tip-to-tip pinch strength (Jaymar dynamometer, kg, higher score = greater strength)
Palmar pinch strength (Jaymar dynamometer, kg, higher score = greater strength)
Key pinch strength (Jaymar dynamometer, kg, higher score = greater strength)
ADLs (1-to-6 scale where 1 = very poor and 6 = excellent; activities unknown)
Outcome time points: baseline, 3 weeks
Notes Source of funding not declared.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Patients were randomly divided into 2 groups using a
table of random numbers”
Allocation concealment (selection bias) Unclear risk No method described.
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Buljina 2001 (Continued)
Blinding of participants
All outcomes
High risk Not possible
Blinding of personnel
All outcomes
High risk Not possible
Blinding of outcome assessment (detection
bias)
Self-reported outcomes
High risk Participants were aware of treatment allocation.
Blinding of outcome assessment (detection
bias)
Objective outcomes
Unclear risk Quote: “All patients were assessed by 2 physiatrists, one of whom
was unaware of the patient’s study group assignment. The partic-
ipants were first assessed by the “blinded” physiatrist, followed
by the second physiatrist’s assessment the next day. Final patient
evaluations were conducted in the same manner at the end of
the 3-week study period. Patients were instructed to avoid dis-
cussing their group assignment.”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No withdrawals or missing data reported.
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias Low risk None
Cima 2013
Methods RCT
Participants 20 participants (13 intervention group, 7 control group), women diagnosed with
rheumatoid arthritis and presenting deformity in at least 1 of the fingers of each hand,
ulnar deviation obligatorily present in both hands
Mean age: 53 (10) intervention group; 60.4 (7.4) control group
Country: Brazil
Interventions 12 supervised exercises comprising co-ordination, range of movement, and strengthen-
ing, 2 times/week for 2 months (20 sessions)
Unsupervised exercises excluding those using equipment, 3 times/week on alternate days
to supervised sessions, total 5 days per week
Control: no treatment
Outcomes Health Assessment Questionnaire (0 to 3, lower score = greater improvement)
Handgrip strength (dynamometer, kgf, higher score = greater strength)
Pinch grip strength (pinch gauge, kgf, higher score = greater strength)
Outcome time points: baseline; 10 sessions and 20 sessions (approximately 2 months)
for intervention; 2 months for control
Notes Funding source declared: State of Sao Paulo Foundation for Research
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Cima 2013 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “The women ... were randomised (by a computer-gen-
erated program) ...”
Allocation concealment (selection bias) Unclear risk Not specified
Blinding of participants
All outcomes
High risk Not possible
Blinding of personnel
All outcomes
High risk Quote: “The evaluator and the research therapists were not
blinded because they were involved in the processes of assess-
ment and intervention ...”
Blinding of outcome assessment (detection
bias)
Self-reported outcomes
High risk Participants were aware of treatment allocation.
Blinding of outcome assessment (detection
bias)
Objective outcomes
High risk Quote: “The evaluator and the research therapists were not
blinded because they were involved in the processes of assess-
ment and intervention ...”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Losses due to transportation and personal issues; none due to
exacerbation of symptoms
Selective reporting (reporting bias) Low risk Raw data supplied on request.
Other bias High risk No baseline characteristics other than age
Dellhag 1992
Methods RCT
Participants 52 participants (13 intervention group 1; 11 intervention group 2; 15 intervention group
3; 13 control) with sero-positive rheumatoid arthritis; disease duration 6 to 10 years; 19
male, 33 female; age range 29 to 69; Streinbrocker functional class I-II; decreased ROM
or grip strength, or both
Country: Sweden
Interventions Intervention group 1: wax bath and ROM exercises 3 times per week for 4 weeks
Intervention group 2: ROM exercise only 3 times per week for 4 weeks
Intervention group 3: wax bath only 3 times per week for 4 weeks
Control group: no treatment
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Dellhag 1992 (Continued)
Outcomes Finger flexion deficit (ruler, mm, higher score = greater impairment)
Finger extension deficit (ruler, mm, higher score = greater impairment)
Total grip function dominant hand (Sollerman test, 0-to-80 scale, higher score = better
grip function)
Pinch grip function dominant hand (Sollerman test, 0-to-32 scale, higher score = better
grip function)
Grip strength (Grippit electronic instrument, N, higher score = greater strength)
Pain during grip function tests (10-point scale, higher score = greater pain)
Pain during finger movement (0-to-100-millimetre VAS, higher score = greater pain)
Hand stiffness (0-to-100-millimetre VAS, higher score = greater stiffness)
Outcome time points: baseline, 4 weeks
Notes Source of funding declared: supported by a grant from Riksforbundet mot Reumatism,
Stockholm
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “Patients were randomised into four groups using se-
quential allocation according to sex, age, duration of the disease,
and/or previous hand surgery”; no method described
Allocation concealment (selection bias) Unclear risk No method described.
Blinding of participants
All outcomes
High risk Not possible
Blinding of personnel
All outcomes
High risk Not possible
Blinding of outcome assessment (detection
bias)
Self-reported outcomes
High risk Participants were aware of treatment allocation.
Blinding of outcome assessment (detection
bias)
Objective outcomes
Unclear risk Quote: “Two occupational therapists ... did all measurements,
the same therapist seeing the individual patient before and after
treatment ... Subjects were not told the measurement results
during the study period”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No withdrawals or missing data reported.
Selective reporting (reporting bias) Low risk All outcomes reported as described in methods apart from pre-
post session pain
Other bias Low risk None
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Hoenig 1993
Methods RCT
Participants 57 participants (14 intervention group 1; 16 intervention group 2; 16 intervention group
3; 11 control group) with rheumatoid arthritis according to the ARA criteria who had
no change in medication for 6 weeks prior to enrolment
Country: USA
Interventions Intervention group 1: ROM home exercise programme for hands performed twice daily
for 12 weeks
Intervention group 2: strengthening home exercise programme for hands performed
twice daily for 12 weeks
Intervention group 3: ROM and strengthening exercise programme for hands performed
twice daily for 12 weeks
Control group: no treatment
Outcomes Grip strength (aneroid manometer, mmHg, higher score = greater strength)
MCP extension ROM (goniometer, degrees, higher score = greater movement)
PIP extension ROM (goniometer, degrees, higher score = greater movement)
Hand articular index (Ritchie articular index, higher score = greater disease activity)
PIP circumference (arthrocircometer, cm, higher score = greater swelling)
Ulnar deviation of 3rd digit (goniometer, degrees, higher score = greater deformity)
clinician rating of hand deformities (no detail given)
dexterity (9-hole peg test, seconds, greater score = worse dexterity)
Morning stiffness (participant reported, minutes, higher score = worse stiffness)
Hand pain (VAS, higher score = greater pain)
Arthritis severity (no details given)
Medication dosage/frequency (participant reported)
Outcome time points: baseline; 3 months; 6 months (exercise group only)
Notes Funding source declared: The Bassett Research Foundation and Fred Sammons, Inc
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Consecutive patients were randomly assigned in blocks
of 4, using a random numbers table, to 1 of 3 exercise groups or
a control group”
Allocation concealment (selection bias) Unclear risk No method described.
Blinding of participants
All outcomes
High risk All 3 exercise regimens were demonstrated by the OT, although
participants were aware that they would carry out only 1 of the
regimens, depending on their assignment
Blinding of personnel
All outcomes
Low risk Quote: “Treating physicians and OT evaluator were unaware of
the patient’s study group assignment. Patients were instructed
to avoid discussing their exercise assignment with either the OT
evaluator or their physician and to contact one of the investiga-
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Hoenig 1993 (Continued)
tors with questions or problems.”
Blinding of outcome assessment (detection
bias)
Self-reported outcomes
High risk Participants were aware of treatment allocation.
Blinding of outcome assessment (detection
bias)
Objective outcomes
Low risk Quote: “Treating physicians and OT evaluator were unaware of
the patient’s study group assignment. Patients were instructed
to avoid discussing their exercise assignment with either the OT
evaluator or their physician and to contact one of the investiga-
tors with questions or problems.”
Incomplete outcome data (attrition bias)
All outcomes
High risk Quote: “Our data were analysed excluding noncompliant pa-
tients and patients who had changes in their medication.”
Selective reporting (reporting bias) High risk No data or comments regarding morning stiffness, hand pain,
or severity of arthritis provided
Other bias High risk Contamination risk: all 3 exercise regimens were demonstrated
by the OT, although participants were aware that they would
carry out only 1 of the regimens, depending on their assignment
Lamb 2015
Methods RCT
Participants 490 participants randomised (2 withdrew use of data consent); 374 females, 114 males
Adults (≥ 18 years) with RA with pain and dysfunction of hands who were either not on
a DMARD regimen, or who had been on a stable DMARD regimen (including biologic
agents if used) for 3 months or beyond
Country: UK
Interventions 7 mobility exercises (1 set x 5 reps), progression with increased reps (max 10) and
increased hold time (max 10 seconds)
4 strengthening exercises (1 set x 10 reps (min 8, max 12) x 10 of initial load between
3 to 4 on modified 10-point Borg scale), stepwise progression of increased reps, and
increased Borg scale scores
6 contact sessions, of which 5 were exercise sessions
Daily at home in between exercise sessions
Usual care control comprising an initial assessment and the provision of joint protection
information, splinting, assistive devices, and other general advice as required
Outcomes Hand function: MHQ - overall hand function subscale; summed MHQ score - partici-
pant-reported questionnaire; range 0 to 100 (higher score indicates greater function)
Pain: pain subscale of the MHQ - questionnaire; 0 to 100 (high score is worse) Trouble-
someness grid: questionnaire; 0 to 20 (higher score indicates greater pain)
Activities of daily living: subscale of the MHQ - questionnaire; range 0 to 100 (higher
score indicates greater function)
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Lamb 2015 (Continued)
Work performance subscale of the MHQ: questionnaire; range 0 to 100 (higher score
indicates greater function)
Satisfaction: subscale of theMHQ - questionnaire; range 0 to 100 (higher score indicates
greater function)
Self reported improvement: participant-rated global change questionnaire; range 1-to-
7-point Likert scale (”completely recovered“ to ”vastly worsened“ - higher score = better
outcome)
Self reported benefit/harm of treatment: treatment satisfaction questionnaire; range 1 to
5 (”substantial benefit“ to ”substantial harm“)
Satisfaction questions: range 1 to 7 (extremely dissatisfied to extremely satisfied)
Aesthetics: subscale of the MHQ - questionnaire; range 0 to 100 (higher score indicates
greater function)
Grip strength: MIE digital grip analyser in the standard test position recommended by
the American Society of Hand Therapists; N (higher value = better)
Pinch grip: MIE digital grip analyser in the standard test position recommended by the
American Society of Hand Therapists; N (higher value = better)
Dexterity: 9-hole peg test; seconds (higher score is worse)
Hand and wrist active range of motion: wrist flexion and extension from the neutral
position - goniometer; degrees (greater score = greater movement)
Combined finger flexion and combined finger extension: ruler; mm (lesser score = greater
movement)
Thumb opposition: observation; 0 to 10 (higher value = better)
Joint alignment/deformity: MCP ulnar/radial deviation in maximum pronation, where
ulnar deviation is recorded as a positive value - goniometer; degrees (higher score is
worse)
Self efficacy: Arthritis Self-Efficacy Scale - 7-item questionnaire (higher score = greater
self efficacy)
Changes in disease activity: ESR; mm/hour
C-reactive protein: blood tests, collected from patient records; mg/litre
Tender and swollen joint count of the hands and wrists: examination; count 0 to 22
(high score is worse)
Quality of life: 12-Item Short Form Health Survey (SF-12) (mental and physical); range
0 to 100 (higher scores = higher quality of life); EQ-5D: range 0 to 1 (higher score =
better outcome)
Exercise adherence: 5-item self reported current exercise behaviour questionnaire >/= 1
to 2 sessions per week
Economics: resource use questionnaire; cost per quality adjusted life year
Outcome time points: baseline; 4 months; 12 months
Notes Funding source declared: National Institute for Health Research Health Technology
assessment programme
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: ”We used a central telephone randomisation service ...“
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Lamb 2015 (Continued)
Allocation concealment (selection bias) Low risk Quote: “Allocation was computer-generated and only revealed
once the participant was registered into the trial ... The research
clinicianwill then telephone the randomisation service, and once
the patient is registered in the trial, will the random allocation
be generated”
Blinding of participants
All outcomes
High risk Quote: “It was not possible to mask participants and therapists
to treatment allocation.”
Blinding of personnel
All outcomes
High risk Quote: “It was not possible to mask participants and therapists
to treatment allocation.“
Blinding of outcome assessment (detection
bias)
Self-reported outcomes
High risk Participants were aware of allocation.
Blinding of outcome assessment (detection
bias)
Objective outcomes
Low risk Quote: ”The outcome assessors were independent of interven-
tion delivery and masked to group allocation. Participants were
asked not to reveal allocation to the assessors at follow-up. We
asked outcome assessors if they could guess the allocation of par-
ticipants at the end of each assessment.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “The analysis was intention to treat”; “We used pub-
lished score specific guidance for managing missing data and in-
vestigated the effects of missing data using multiple imputation
analysis.”
Selective reporting (reporting bias) Low risk All outcomes reported.
Other bias Low risk Quote: “None of the authors declare any conflict of interest”;
“The randomised groups were well matched in clinical and de-
mographic characteristics.”
O’Brien 2006
Methods RCT
Participants 67 participants (21 intervention group 1; 24 intervention group 2; 22 control group)
with rheumatoid arthritis according to ACR criteria; stable medication for 3 months
prior to enrolment; not on oral or injected corticosteroids; 21 male, 46 female; > 18
years; no surgery in the 6 months prior to enrolment; no sensory impairment to hands;
and not pregnant
Country: UK
Interventions Intervention group1: joint protection advice plus strengthening andROMhome exercise
programme twice daily for 6 months taught by a musculoskeletal therapist
Intervention group 2: joint protection advice plus ROMhome exercise programme twice
daily for 6 months taught by a musculoskeletal therapist
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O’Brien 2006 (Continued)
Control group: joint protection advice taught by a musculoskeletal therapist
Outcomes Primary:
AIMS II (0 to 10; higher score = reduced function)
Secondary:
Jebsen-Taylor hand function test (seconds, higher score = reduced function)
Power grip (Jamar, lbs, higher score = greater strength)
Key pinch (pinch gauge, lbs, higher score = greater strength)
Dominant hand index nger exion goniometry (goniometer, degrees, higher score =
greater ROM)
Swollen and tender joint scores (no details)
Patients’ perceptions of their own disease activity (0-to-10-centimetre VAS, direction
not reported)
Change in DMARD (yes/no)
Outcome time points: baseline; 1 month; 3 months; 6 months
Notes Funding source declared: Promedics UK, Birmingham branch of Chartered Society of
Physiotherapy
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “A computer-generated randomisation list with per-
muted blocks within strata (17) was devised which stratified by
length of time since diagnosis (less than or beyond than 5 yr) as
well as rheumatoid factor serology (positive or negative).”
Allocation concealment (selection bias) Low risk Quote: “Following screening and consent, the research physio-
therapist telephoned a blinded third party (from a central ad-
ministrative team) informing them of stratification details; this
person then subsequently identified treatment allocation. The
research therapist ... then referred the participant to the treating
therapist ... who undertook the allocated treatment according
to a protocol.”
Blinding of participants
All outcomes
High risk Not possible
Blinding of personnel
All outcomes
High risk Not possible
Blinding of outcome assessment (detection
bias)
Self-reported outcomes
High risk Participants were aware of treatment allocation.
Blinding of outcome assessment (detection
bias)
Low risk Quote: “(Following randomisation) the research therapist ...
then referred the participant to the treating therapist ... who
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O’Brien 2006 (Continued)
Objective outcomes undertook the allocated treatment according to a protocol. All
outcome assessments were undertaken blinded at baseline, 1, 3
and 6 months by one of two additional therapists ...”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “An intention to treat analysis was undertaken”
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias Low risk Quote: “Participants in group 1 were older and had longer mean
disease duration and higher scores for all disease activity mea-
sures compared with participants in groups 2 and 3, although
differences were not statistically significant.” Note: AIMS II ad-
justed for baseline values
ACR: American College of Rheumatology
ADL: activities of daily living
AIMS: Arthritis Impact Measurement Scale
ARA: American Rheumatism Association
CRP: C-reactive protein
DMARDs: disease-modifying antirheumatic drugs
ESR: erythrocyte sedimentation rate
HAQ: Health Assessment Questionnaire
kgf: kilogram-force
MCP: metacarpophalangeal
MHQ: Michigan Hand Outcomes Questionnaire
OT: occupational therapist
PIP: proximal interphalangeal
RCT: randomised controlled trial
RF: rheumatoid factor
ROM: range of motion
VAS: visual analogue scale
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Azeez 2014 Did not evaluate an exercise programme specific to the hand or wrist
Baillet 2009 Did not evaluate an exercise programme specific to the hand or wrist
Bearne 2012 Did not evaluate an exercise programme specific to the hand or wrist
Berntzen 2016 Did not evaluate an exercise programme specific to the hand or wrist
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Brorsson 2009 Study did not use a randomised design.
Brorsson 2014 Did not compare an exercise programme to a non-exercise comparator
Byers 1985 Did not compare an exercise programme to a non-exercise comparator
Cakir 2014 Did not evaluate an exercise programme specific to the hand or wrist
Dash 2001 Did not evaluate an exercise programme specific to the hand or wrist
De Jong 2004 Did not evaluate an exercise programme specific to the hand or wrist
Dogu 2013 Did not compare an exercise programme to a non-exercise comparator
Dulgeroglu 2014 Did not compare an exercise programme to a non-exercise comparator
Dülgero lu 2016 Did not compare an exercise programme to a non-exercise comparator
Flint-Wagner 2009 Did not evaluate an exercise programme specific to the hand or wrist
Hammond 2004a Did not compare an exercise programme to a non-exercise comparator
Hansen 1993 Did not evaluate an exercise programme specific to the hand or wrist
Hawkes 1985 Did not compare an exercise programme to a non-exercise comparator
Hawkes 1986 Did not compare an exercise programme to a non-exercise comparator
Khedekar 2017 Did not compare an exercise programme to a non-exercise comparator
Kiraly 2015 Did not evaluate an exercise programme specific to the hand or wrist
Lineker 2001 Did not evaluate an exercise programme specific to the hand or wrist
Maxwell 2005 Study did not use a randomised design.
Minor 1995 Did not evaluate an exercise programme specific to the hand or wrist
Orlova 2016 Did not evaluate an exercise programme specific to the hand or wrist
Piga 2014 Did not compare an exercise programme to a non-exercise comparator
Pineda-Juárez 2016 Did not evaluate an exercise programme specific to the hand or wrist
Pot-Vaucel 2016 Did not evaluate an exercise programme specific to the hand or wrist
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Rapoliene 2006 Study did not use a randomised design.
Ronningen 2008 Study did not use a randomised design.
Seneca 2015 Did not evaluate an exercise programme specific to the hand or wrist
Shapoorabadi 2016 Did not evaluate an exercise programme specific to the hand or wrist
Srikesavan 2016 Did not compare an exercise programme to a non-exercise comparator
Tee 2016 Did not evaluate an exercise programme specific to the hand or wrist
Veitiene 2004 Did not compare an exercise programme to a non-exercise comparator
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D A T A A N D A N A L Y S E S
Comparison 1. Exercise versus no exercise
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Hand function 1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
1.1 Medium term (3 to 11
months)
1 449 Mean Difference (IV, Fixed, 95% CI) 4.5 [1.58, 7.42]
1.2 Long term (12 months or
more)
1 438 Mean Difference (IV, Fixed, 95% CI) 4.30 [0.86, 7.74]
2 Pain 3 Mean Difference (IV, Random, 95% CI) Subtotals only
2.1 Pain scores: short term (<
3 months)
2 124 Mean Difference (IV, Random, 95% CI) -27.98 [-48.93, -7.
03]
2.2 Pain scores: medium term 1 445 Mean Difference (IV, Random, 95% CI) -2.80 [-6.96, 1.36]
2.3 Pain scores: long term 1 437 Mean Difference (IV, Random, 95% CI) -3.70 [-8.10, 0.70]
3 Hand impairment - power grip
strength: short term
3 Std. Mean Difference (IV, Fixed, 95% CI) Subtotals only
3.1 Power grip strength - left
hand: short term
3 141 Std. Mean Difference (IV, Fixed, 95% CI) 0.44 [0.11, 0.78]
3.2 Power grip strength - right
hand: short term
3 141 Std. Mean Difference (IV, Fixed, 95% CI) 0.46 [0.13, 0.80]
4 Hand impairment - power grip
strength: medium and long
term
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
4.1 Mean power grip strength
of both sides: medium term
1 400 Mean Difference (IV, Fixed, 95% CI) 1.40 [-0.27, 3.07]
4.2 Mean power grip strength
of both sides: long term
1 355 Mean Difference (IV, Fixed, 95% CI) 1.20 [-0.62, 3.02]
5 Hand impairment - pinch grip
strength
3 Mean Difference (IV, Fixed, 95% CI) Subtotals only
5.1 Pinch grip strength - left
hand: short term
2 120 Mean Difference (IV, Fixed, 95% CI) 0.51 [0.13, 0.90]
5.2 Pinch grip strength - right
hand: short term
2 120 Mean Difference (IV, Fixed, 95% CI) 0.82 [0.43, 1.21]
5.3 Mean pinch grip strength
of both sides: medium term
1 396 Mean Difference (IV, Fixed, 95% CI) 0.30 [-0.14, 0.74]
5.4 Mean pinch grip strength
of both sides: long term
1 351 Mean Difference (IV, Fixed, 95% CI) 0.40 [-0.08, 0.88]
6 Participant adherence 1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
6.1 Participant adherence:
medium term
1 438 Risk Ratio (M-H, Fixed, 95% CI) 1.31 [1.15, 1.48]
6.2 Participant adherence:
long term
1 422 Risk Ratio (M-H, Fixed, 95% CI) 1.09 [0.93, 1.28]
7 General function 3 Std. Mean Difference (IV, Fixed, 95% CI) Subtotals only
7.1 Short term 2 120 Std. Mean Difference (IV, Fixed, 95% CI) 0.79 [0.42, 1.17]
7.2 Medium term 1 449 Std. Mean Difference (IV, Fixed, 95% CI) 1.45 [1.24, 1.66]
8 Disease activity 2 Std. Mean Difference (IV, Fixed, 95% CI) Subtotals only
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8.1 Swollen joint count:
medium term
2 492 Std. Mean Difference (IV, Fixed, 95% CI) -0.16 [-0.34, 0.01]
8.2 Tender joint count:
medium term
2 492 Std. Mean Difference (IV, Fixed, 95% CI) -0.19 [-0.37, -0.01]
Analysis 1.1. Comparison 1 Exercise versus no exercise, Outcome 1 Hand function.
Review: Exercise for rheumatoid arthritis of the hand
Comparison: 1 Exercise versus no exercise
Outcome: 1 Hand function
Study or subgroup Exercise No Exercise
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Medium term (3 to 11 months)
Lamb 2015 222 61.1 (16) 227 56.6 (15.6) 100.0 % 4.50 [ 1.58, 7.42 ]
Subtotal (95% CI) 222 227 100.0 % 4.50 [ 1.58, 7.42 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.02 (P = 0.0026)
2 Long term (12 months or more)
Lamb 2015 216 60.7 (18.1) 222 56.4 (18.6) 100.0 % 4.30 [ 0.86, 7.74 ]
Subtotal (95% CI) 216 222 100.0 % 4.30 [ 0.86, 7.74 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.45 (P = 0.014)
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Analysis 1.2. Comparison 1 Exercise versus no exercise, Outcome 2 Pain.
Review: Exercise for rheumatoid arthritis of the hand
Comparison: 1 Exercise versus no exercise
Outcome: 2 Pain
Study or subgroup Exercise No Exercise
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Pain scores: short term (< 3 months)
Buljina 2001 50 32.4 (14.78) 50 70 (19.04) 55.3 % -37.60 [ -44.28, -30.92 ]
Dellhag 1992 11 17 (18.95) 13 33.1 (18.95) 44.7 % -16.10 [ -31.32, -0.88 ]
Subtotal (95% CI) 61 63 100.0 % -27.98 [ -48.93, -7.03 ]
Heterogeneity: Tau2 = 195.18; Chi2 = 6.43, df = 1 (P = 0.01); I2 =84%
Test for overall effect: Z = 2.62 (P = 0.0089)
2 Pain scores: medium term
Lamb 2015 219 43.3 (23.6) 226 46.1 (21.1) 100.0 % -2.80 [ -6.96, 1.36 ]
Subtotal (95% CI) 219 226 100.0 % -2.80 [ -6.96, 1.36 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.32 (P = 0.19)
3 Pain scores: long term
Lamb 2015 215 41.6 (24.3) 222 45.3 (22.6) 100.0 % -3.70 [ -8.10, 0.70 ]
Subtotal (95% CI) 215 222 100.0 % -3.70 [ -8.10, 0.70 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.65 (P = 0.10)
Test for subgroup differences: Chi2 = 5.34, df = 2 (P = 0.07), I2 =63%
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Analysis 1.3. Comparison 1 Exercise versus no exercise, Outcome 3 Hand impairment - power grip
strength: short term.
Review: Exercise for rheumatoid arthritis of the hand
Comparison: 1 Exercise versus no exercise
Outcome: 3 Hand impairment - power grip strength: short term
Study or subgroup Exercise No Exercise
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Power grip strength - left hand: short term
Buljina 2001 50 18.5 (8.77) 50 14.24 (7.97) 71.5 % 0.50 [ 0.11, 0.90 ]
Cima 2013 13 15.73 (6.69) 7 12.83 (8.58) 13.2 % 0.38 [ -0.55, 1.30 ]
Hoenig 1993 10 96.8 (71.6) 11 81.1 (64.7) 15.4 % 0.22 [ -0.64, 1.08 ]
Subtotal (95% CI) 73 68 100.0 % 0.44 [ 0.11, 0.78 ]
Heterogeneity: Chi2 = 0.37, df = 2 (P = 0.83); I2 =0.0%
Test for overall effect: Z = 2.58 (P = 0.0097)
2 Power grip strength - right hand: short term
Buljina 2001 50 19.82 (9.43) 50 15.33 (8.88) 71.8 % 0.49 [ 0.09, 0.88 ]
Cima 2013 13 16.63 (6.19) 7 12.52 (7.64) 12.8 % 0.59 [ -0.35, 1.53 ]
Hoenig 1993 10 97.6 (68.4) 11 81.1 (60.1) 15.4 % 0.25 [ -0.61, 1.11 ]
Subtotal (95% CI) 73 68 100.0 % 0.46 [ 0.13, 0.80 ]
Heterogeneity: Chi2 = 0.32, df = 2 (P = 0.85); I2 =0.0%
Test for overall effect: Z = 2.69 (P = 0.0072)
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Analysis 1.4. Comparison 1 Exercise versus no exercise, Outcome 4 Hand impairment - power grip
strength: medium and long term.
Review: Exercise for rheumatoid arthritis of the hand
Comparison: 1 Exercise versus no exercise
Outcome: 4 Hand impairment - power grip strength: medium and long term
Study or subgroup Exercise No exercise
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Mean power grip strength of both sides: medium term
Lamb 2015 195 15.6 (8.9) 205 14.2 (8.1) 100.0 % 1.40 [ -0.27, 3.07 ]
Subtotal (95% CI) 195 205 100.0 % 1.40 [ -0.27, 3.07 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.64 (P = 0.10)
2 Mean power grip strength of both sides: long term
Lamb 2015 171 16 (9.1) 184 14.8 (8.3) 100.0 % 1.20 [ -0.62, 3.02 ]
Subtotal (95% CI) 171 184 100.0 % 1.20 [ -0.62, 3.02 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.29 (P = 0.20)
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Analysis 1.5. Comparison 1 Exercise versus no exercise, Outcome 5 Hand impairment - pinch grip strength.
Review: Exercise for rheumatoid arthritis of the hand
Comparison: 1 Exercise versus no exercise
Outcome: 5 Hand impairment - pinch grip strength
Study or subgroup Exercise No exercise
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Pinch grip strength - left hand: short term
Buljina 2001 50 1.56 (1.11) 50 1.1 (0.93) 92.5 % 0.46 [ 0.06, 0.86 ]
Cima 2013 13 3.56 (1.27) 7 2.41 (1.66) 7.5 % 1.15 [ -0.26, 2.56 ]
Subtotal (95% CI) 63 57 100.0 % 0.51 [ 0.13, 0.90 ]
Heterogeneity: Chi2 = 0.85, df = 1 (P = 0.36); I2 =0.0%
Test for overall effect: Z = 2.60 (P = 0.0094)
2 Pinch grip strength - right hand: short term
Buljina 2001 50 2.02 (1.15) 50 1.2 (0.93) 91.4 % 0.82 [ 0.41, 1.23 ]
Cima 2013 13 3.83 (1.2) 7 3.02 (1.57) 8.6 % 0.81 [ -0.52, 2.14 ]
Subtotal (95% CI) 63 57 100.0 % 0.82 [ 0.43, 1.21 ]
Heterogeneity: Chi2 = 0.00, df = 1 (P = 0.99); I2 =0.0%
Test for overall effect: Z = 4.10 (P = 0.000042)
3 Mean pinch grip strength of both sides: medium term
Lamb 2015 192 4.6 (2.3) 204 4.3 (2.2) 100.0 % 0.30 [ -0.14, 0.74 ]
Subtotal (95% CI) 192 204 100.0 % 0.30 [ -0.14, 0.74 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.32 (P = 0.19)
4 Mean pinch grip strength of both sides: long term
Lamb 2015 169 4.8 (2.5) 182 4.4 (2.1) 100.0 % 0.40 [ -0.08, 0.88 ]
Subtotal (95% CI) 169 182 100.0 % 0.40 [ -0.08, 0.88 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.62 (P = 0.11)
-10 -5 0 5 10
Favours no exercise Favours exercise
52Exercise for rheumatoid arthritis of the hand (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.6. Comparison 1 Exercise versus no exercise, Outcome 6 Participant adherence.
Review: Exercise for rheumatoid arthritis of the hand
Comparison: 1 Exercise versus no exercise
Outcome: 6 Participant adherence
Study or subgroup Exercise Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Participant adherence: medium term
Lamb 2015 174/216 137/222 100.0 % 1.31 [ 1.15, 1.48 ]
Subtotal (95% CI) 216 222 100.0 % 1.31 [ 1.15, 1.48 ]
Total events: 174 (Exercise), 137 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 4.26 (P = 0.000020)
2 Participant adherence: long term
Lamb 2015 128/206 123/216 100.0 % 1.09 [ 0.93, 1.28 ]
Subtotal (95% CI) 206 216 100.0 % 1.09 [ 0.93, 1.28 ]
Total events: 128 (Exercise), 123 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.09 (P = 0.28)
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Analysis 1.7. Comparison 1 Exercise versus no exercise, Outcome 7 General function.
Review: Exercise for rheumatoid arthritis of the hand
Comparison: 1 Exercise versus no exercise
Outcome: 7 General function
Study or subgroup Exercise No Exercise
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Short term
Buljina 2001 50 4.24 (1.14) 50 3.24 (1.31) 84.4 % 0.81 [ 0.40, 1.22 ]
Cima 2013 13 -0.85 (0.7) 7 -1.29 (0.29) 15.6 % 0.71 [ -0.24, 1.66 ]
Subtotal (95% CI) 63 57 100.0 % 0.79 [ 0.42, 1.17 ]
Heterogeneity: Chi2 = 0.04, df = 1 (P = 0.85); I2 =0.0%
Test for overall effect: Z = 4.14 (P = 0.000035)
2 Medium term
Lamb 2015 222 62.9 (24.1) 227 26.9 (25.5) 100.0 % 1.45 [ 1.24, 1.66 ]
Subtotal (95% CI) 222 227 100.0 % 1.45 [ 1.24, 1.66 ]
Heterogeneity: not applicable
Test for overall effect: Z = 13.64 (P < 0.00001)
Test for subgroup differences: Chi2 = 8.97, df = 1 (P = 0.00), I2 =89%
-2 -1 0 1 2
Favours no exercise Favours exercise
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Analysis 1.8. Comparison 1 Exercise versus no exercise, Outcome 8 Disease activity.
Review: Exercise for rheumatoid arthritis of the hand
Comparison: 1 Exercise versus no exercise
Outcome: 8 Disease activity
Study or subgroup Exercise No Exercise
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Swollen joint count: medium term
Lamb 2015 222 3.2 (4.6) 227 4 (5.3) 91.3 % -0.16 [ -0.35, 0.02 ]
O’Brien 2006 21 2.33 (3.52) 22 3.27 (5.59) 8.7 % -0.20 [ -0.80, 0.40 ]
Subtotal (95% CI) 243 249 100.0 % -0.16 [ -0.34, 0.01 ]
Heterogeneity: Chi2 = 0.01, df = 1 (P = 0.91); I2 =0.0%
Test for overall effect: Z = 1.81 (P = 0.070)
2 Tender joint count: medium term
Lamb 2015 222 3.4 (4.5) 227 4.4 (5) 91.2 % -0.21 [ -0.40, -0.02 ]
O’Brien 2006 21 2.53 (3.66) 22 2.53 (4.5) 8.8 % 0.0 [ -0.60, 0.60 ]
Subtotal (95% CI) 243 249 100.0 % -0.19 [ -0.37, -0.01 ]
Heterogeneity: Chi2 = 0.43, df = 1 (P = 0.51); I2 =0.0%
Test for overall effect: Z = 2.12 (P = 0.034)
Test for subgroup differences: Chi2 = 0.05, df = 1 (P = 0.83), I2 =0.0%
-2 -1 0 1 2
Favours exercise Favours no exercise
A D D I T I O N A L T A B L E S
Table 1. Characteristics of interventions
Author Exercise arm intervention Control arm intervention
Brighton 1993 1) daily dexterity, ROM, and strengthening exercises for
4 years (with 6-month follow-up visits)
No exercises
Buljina 2001 1) daily faradic baths, wax, ROM, and strengthening
exercise programme for 3 weeks
Waiting list
Dellhag 1992 1) wax bath + exercises; 2) ROM exercises only; 3) wax
bath only, 3 times weekly for 4 weeks
No treatment
Hoenig 1993 1) daily ROM exercises; 2) strengthening exercises; 3)
daily ROM and strengthening. 12-week programme
Normal medication regimen and physician care
55Exercise for rheumatoid arthritis of the hand (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Table 1. Characteristics of interventions (Continued)
O’Brien 2006 1) joint protection + daily ROM+ strengthening; 2) joint
protection + daily ROM for 6 months
Joint protection advice
Cima 2013 1) strengthening exercises; 2) motor co-ordination; 3)
ROM, 5 days a week for 2 months, supervised and un-
supervised
No treatment
Lamb 2015 1) 7 mobility exercises; 2) 4 strength exercises, daily for
12 weeks, supervised and unsupervised
Usual hand care typically provided in UK NHS
NHS: National Health Service; ROM: range of motion
Table 2. Raw data - hand function
Dellhag 1992 O’Brien 2006 Lamb 2015 (also reported in
Williams 2015)
Measurement Grip function, Sollerman test AIMS2 upper limb subscale and
hand and finger function subscale
MHQ overall hand function score
Follow-up periods Baseline, 4 weeks Baseline, 1, 3, and 6 months Baseline, 4 and 12 months
Pre-intervention Group 2 (exercise) 74.8; Group 4
(control) 75.2
----------------------------- Exercise group 52.1 (15.2); con-
trol group 52.1 (16.4)
Postintervention Group 2 (exercise) 76.1; Group 4
(control) 75.0
----------------------------- 4 months:
• exercise group: 61.1 (16.0)
• control group: 56.6 (15.6)
12 months:
• exercise group: 60.7 (18.1)
• control group: 56.4 (18.6)
Change - 0 to 1 month - upper limb sub-
scale:
• Group 1: 0.31 (1.14)
• Group 2: -0.25 (1.08)
• Group 3: -0.22 (1.25)
0 to 4months -MHQoverall hand
function:
• exercise group: 8.73 (6.83 to
10.64)
• control group: 4.04 (2.17 to
5.91)
0 to 3 months - upper limb sub-
scale:
• Group 1: 0.63 (1.59)
• Group 2: -0.56 (1.47)
• Group 3: -0.06 (1.21)
0 to 12 months - MHQ overall
hand function:
• exercise group: 7.93 (5.98 to
9.88)
• control group: 3.56 (1.45 to
5.68)
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Table 2. Raw data - hand function (Continued)
0 to 6 months - upper limb sub-
scale:
• Group 1: 1.00 (1.07)
• Group 2: -0.18 (1.54)
• Group 3: -0.30 (1.22)
-----------------------------
0 to 1 month - hand and finger
function subscale:
• Group 1: 0.97 (1.04)
• Group 2: -0.13 (1.54)
• Group 3: 0.53 (1.37)
0 to 3 months - hand and finger
function subscale:
• Group 1: 0.47 (1.60)
• Group 2: -0.47 (1.41)
• Group 3: 0.34 (1.67)
0 to 6 months - hand and finger
function subscale:
• Group 1: 0.97 (1.72)
• Group 2: 0.18 (2.07)
• Group 3: 0.38 (1.68)
Authors’ conclusions No significant differences between
groups
Statistically significant improve-
ment in test group compared to
control (and mobilising exercises-
alone group)
Statistically significant improve-
ment in exercise group compared
to control
Notes No standard deviations ----------------------------- -----------------------------
AIMS2: Arthritis Impact Measurement Scales 2
MHQ: Michigan Hand Outcomes Questionnaire
Table 3. Raw data - pain
Dellhag 1992 Buljina 2001 Lamb 2015 (also reported in
Williams 2015)
Measurement Pain with non-resisted motion
in both hands, measured by
100-millimetre vertical VAS
Measured by a 0-to-10 VAS,
where 0 indicates a painless con-
dition and 10 most severe pain
Pain subscale of MHQ (0 to
100; high score is worse)
Postintervention assessment
points
4 weeks 3 weeks 4 and 12 months
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Table 3. Raw data - pain (Continued)
Pre-intervention Active hand exercise only (n =
11): 28.8
Wax bath only (n = 15): 20.3
Control (n = 13): 27.7
Pain scores in mm
Physical and exercise therapy
group (n = 50): 66.4 (17.02)
Control group (n = 50): 67.6
(17.51)
MHQ pain subscale, mean
(SD)
Exercise (n = 246): 51.9 (21.9)
Usual care (n = 242): 51.4 (19.
9)
Postintervention At 4 weeks
Active hand exercise only (n =
11): 17.0
Wax bath only (n = 15): 25.9
Control (n = 13): 33.1
Pain scores in mm
At 3 weeks
Physical and exercise therapy
group (n = 50): 32.4 (14.78)
Control group (n = 50): 70 (19.
04)
MHQ pain subscale, mean
(SD)
4 months:
• exercise group (n = 219):
43.3 (23.6)
• usual care (n = 226): 46.1
(21.1)
12 months:
• exercise group (n = 215):
41.6 (24.3)
• usual care (n = 222): 45.3
(22.6)
Change ----------------------------- ----------------------------- MHQ pain subscale
4 months
Mean change from baseline
pain scores (95%confidence in-
terval)
• exercise: -7.6 (-9.94 to -5.
26)
• usual care: -5.11 (-7.58 to
-2.63)
Mean treatment difference, ad-
justed for centre, sex, age, and
drug groups (DMARDs and
oral steroids):
-3.30 (-6.50 to -0.11), P = 0.
0433
12 months
Mean change (95% confidence
interval)
• exercise: -8.26 (-10.83 to
-5.7)
• usual care: -6.01 (-8.74 to
-3.29)
Mean treatment difference, ad-
justed for centre, sex, age, and
drug groups (DMARDs and
oral steroids):
-2.40 (-5.92 to 1.12), P = 0.
1814
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Table 3. Raw data - pain (Continued)
Authors’ conclusions Significant pain reduction in
the exercise only group, P < 0.
05 compared to control group
and compared to group that re-
ceived wax therapy only
Significant improvement in the
physical and exercise therapy
group, P < 0.005
No statistically significant dif-
ferences in pain scores between
groups at 4 and 12 months
Notes No standard deviations ----------------------------- -----------------------------
DMARD: disease-modifying antirheumatic drug
MHQ: Michigan Hand Outcomes Questionnaire
SD: standard deviation
VAS: visual analogue scale
A P P E N D I C E S
Appendix 1. MEDLINE (OVID SP) search strategy
1. exp arthritis, rheumatoid/
2. ((rheumatoid or reumatoid or revmatoid or rheumatic or reumatic or revmatic or rheumat$ or reumat$ or revmarthrit$) adj3 (arthrit$
or artrit$ or diseas$ or condition$ or nodule$)).tw.
3. (felty$ adj2 syndrome).tw.
4. (caplan$ adj2 syndrome).tw.
5. (sjogren$ adj2 syndrome).tw.
6. (sicca adj2 syndrome).tw.
7. still$ disease.tw.
8. bechterew$ disease.tw.
9. or/1-8
10. Hand/
11. wrist/
12. exp Hand Deformities/
13. hand$.tw.
14. wrist$.tw.
15. finger$.tw.
16. Thumb$.tw.
17. or/10-16
18. exp Exercise Therapy/
19. exp Physical Therapy Modalities/
20. exercis$.tw.
21. Physical therap$.tw.
22. physiotherap$.tw.
23. (resistance or strength$).tw.
24. (muscle$ adj (stretch$ or manipulat$)).tw.
25. ((muscle$ or musculoskeletal) adj (stretch$ or manipulat$)).tw.
26. or/18-25
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27. and/9,17,26
28. randomised controlled trial.pt.
29. controlled clinical trial.pt.
30. randomized.ab.
31. placebo.ab.
32. drug therapy.fs.
33. randomly.ab.
34. trial.ab.
35. groups.ab.
36. or/28-35
37. (animals not (humans and animals)).sh.
38. 36 not 37
39. 27 and 38
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
1. We planned in the protocol to report outcome assessments from the included studies in three time frames: short term (< 3
months), medium term (3 to 12 months), and long term (> 12 months). We revised the time frames in the review to: short term (< 3
months), medium term (3 to 11 months), and long term (12 months and beyond).
2. Nicolette Hoxey-Thomas and Cynthia Srikesavan were added as authors.
3. The review title was changed to: ’Exercise for rheumatoid arthritis of the hand’.
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Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome
MeSH check words
Adult; Aged; Aged, 80 and over; Humans; Middle Aged; Young Adult
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